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The increased rate of contralateral prophylactic mastectomy (CPM) among women with 
early stage unilateral breast cancer has raised concerns particularly with the lack of 
evidence for a survival benefit related to the CPM procedure and with the low risk of 
developing contralateral breast cancer among women with early stage sporadic breast 
cancer. The purpose of this quantitative cross-sectional study, using normative decision 
theory as the framework, was to assess the influence of the partner, physician, and media 
on the decision of women with unilateral breast cancer who decided to undergo CPM. 
Women with stage 0 to III early stage unilateral breast cancer ages 20-60 years old who 
underwent CPM at MD Anderson Cancer Center in the U.S. between January of 2010 
and December of 2017 were surveyed on factors influencing their decision to undergo 
CPM. Logistic regression (binomial distribution with logit link) was used to analyze the 
data. The results revealed that partners, physicians, and media all had significant 
influence (p < 0.05) on the decision-making process of women with unilateral breast 
cancer to undergo CPM. The findings of this study may inform policy by highlighting the 
need for decision aids, programs, or tools that help women with unilateral breast cancer 
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Chapter 1: Introduction to the Study  
Women with early stage unilateral breast cancer are electing to have contralateral  
prophylactic mastectomy (CPM) to reduce the risk of developing a contralateral breast 
cancer.  In the United States, the CPM rate for the surgically treated women with stages I 
to III unilateral breast cancer increased dramatically from 1998 to 2003 (Baker et al., 
2013). Another study showed that the rate of CPM among women with unilateral 
invasive breast cancer increased from 2.2% in 1998 to 11% in 2011 (Jemal et al., 2015). 
Breast cancer patients should understand the benefits versus the risks of CPM in order to 
make informed decisions. The purpose of this study was to examine the influence of 
physicians, partners, and media on the decision-making process of women with unilateral 
early stage breast cancer who decided to undergo CPM. This study was needed because 
breast cancer patients can be influenced by others and may not be making informed 
decisions about engaging in this aggressive and irreversible procedure (CPM).  This 
chapter will include a discussion of the study background, problem statement, purpose of 
study, research questions and hypotheses, theoretical framework, nature of the study, 
definition of terms, assumptions, limitations and significance of the study.  
Background of the Study 
Contralateral prophylactic mastectomy (CPM) is a procedure that women may 
choose in order to prevent breast cancer in the healthy breast. The rate of CPM in the 
United States has more than doubled from 1.8% in 1998 to 4.5 % in 2003 (Tuttle, 
Habermann, Grund, Morris, & Virnig, 2007). The trend of the increasing rate of CPM 
among women with unilateral breast cancer has raised concern, particularly with the lack 
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of evidence for a survival benefit related to the CPM procedure (Tracy, Rosenberg, 
Dominici, & Partridge, 2013), and with the minimal (0.5%-0.75%) annual risk of women 
with early stage sporadic breast cancer for developing contralateral breast cancer 
(Brewster & Parker, 2011). Women might be choosing this procedure to ease their fear of 
recurrence, and by believing that CPM may improve their quality of life; others might be 
influenced by their physicians, partners, or even the media. In a small percentage of 
women, CPM is performed because of cancer in both breasts (Komen, 2012). The 
decision to undergo the CPM procedure should not be made without considerable thought 
(Komen, 2012). The National Comprehensive Cancer Network (NCCN) guidelines are 
discouraging women from considering CPM to help lower their incidence of developing 
breast cancer in their healthy breast and recommending that this procedure should only 
take place if women are considered at high risk of breast cancer (Komen, 2012).  
Several clinical and pathological factors may be related to an increased risk for 
developing contralateral breast cancer in women with unilateral breast cancer. Some of 
these factors are young patient age, family history of breast cancer, chest radiation, 
lobular type histology, and multicentric cancer (Tuttle et al., 2007). In addition, patients 
who tested positive for BRCA1 and BRCA2 genetic mutations are at high risk for 
developing contralateral breast cancer. However, for most women with early stage 
sporadic unilateral breast cancer, the risk of a contralateral breast cancer is low (Brewster 
& Parker, 2011).  
The increased rate of CPM is concerning among the group of women with low 
annual risk for developing contralateral breast cancer. CPM can greatly lower the risk of 
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developing breast cancer in the healthy breast but does not increase the overall survival 
rate and is not usually recommended (Komen, 2012). Tuttle et al. (2007) shared in their 
study that the effectiveness of CPM on reducing breast cancer mortality is still unclear 
and they suggested that further studies are critically needed in order to evaluate the 
patients’ decision-making process that leads patients to consider CPM. Several factors 
can affect the decision-making process of women with unilateral breast cancer to undergo 
CPM but a gap exists in the literature because few studies have examined the influence of 
partner, physician and the media on the decision making process.  The National Cancer 
Institute is discouraging this aggressive and irreversible procedure by stating that it is 
unnecessary for preventing contralateral breast cancer in most patients (NCI, 2007). The 
Mayo Clinic study demonstrated that many women have had unnecessary surgery 
(Siroky, 2012). This study was needed because the lack of information regarding the 
clinical benefits of CPM for women with sporadic or early stage breast cancer, as well as 
the influence of physicians, partner, or media on the CPM decision making process is a 
major area of public health concern. While researchers may know the factors that are 
influencing the decision-making process of women with unilateral breast cancer to 
undergo CPM, research was needed in order to develop a decision quality tool that helps 
women with unilateral breast cancer make an informed decision regarding their surgical 
choice. The decision quality tool could be a brochure that includes but not limited to the 
indication for the CPM procedure, the necessity and the medically unnecessary indication 
of the procedure, doctor’s recommendation, the pro and cons of the procedure, the 
complications, and frequently asked questions, as well as feedbacks from patients who 
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did and did not choose CPM. The patient should have good knowledge regarding the 
irreversible procedure so they can make a shared informed decision about their treatment 
options. 
Problem Statement 
CPM is a procedure that women with unilateral breast cancer may choose because 
the scientific evidence suggests it might prevent breast cancer in the healthy breast. There 
are various reasons for the increase in CPM rates, but few studies have examined the 
influence of partner, physician, as well as the media on the women's decision-making 
process. Frost et al. (2005) identified in their study that the most frequently cited reasons 
for women with unilateral breast cancer to undergo CPM included the physician advice 
and the family history of breast cancer. Partners can also play a major role in the 
decision-making process. Women-partner shared decision-making is vital especially 
since the adjustment to body image after mastectomy can be a gradual and lengthy 
process. Physician-patient communication is also critically important in patients 
diagnosed with unilateral breast cancer. Women should be educated about their disease 
and the available treatment options so that they can make informed decisions related to 
their care. 
The media may influence the decision-making process as well.  The internet, 
television, radio, and advertising are easily accessible by individuals and can affect 
an individual’s decisions. The media sometimes quotes physicians, scientists, 
researchers, and many experts on the latest medical developments, so it might be 
difficult for people who do not have appropriate background knowledge to 
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disagree. Some medical companies may also use famous people to advertise for 
their products; these companies will publicize the fact that these celebrities agree 
with their point of view, product, or procedure, possibly because they believe that 
the general public holds celebrities in high regard. Some of the best-known 
examples for this trend are two famous actresses, Christina Applegate and Angelina 
Jolie. Christina Applegate was diagnosed with unilateral breast cancer in 2008 but 
opted to remove her healthy breast along with the affected breast (OSU, 2010). 
Applegate had a family history of breast cancer and tested positive for mutations in 
the BRCA gene. Angelina Jolie, who also tested positive for mutations in the 
BRCA1 gene, underwent a radical double mastectomy to lower her risk of 
developing cancer (Park, 2013). Kamenova et al. (2014) study highlighted the 
media’s overwhelming positive slant toward Angelina Jolie’s mastectomy while 
overlooked the other factors in her case, the challenges of “celebrity medicine ,” 
and how celebrities can influence people’s medical decisions. Media don’t usually 
gives details regarding BRCA mutation and what it means.  Researchers from the 
University of Michigan analyzed 727 articles from major U.S. print publications 
that covered celebrities’ breast cancer diagnoses and concluded that an increase in 
rate of women with breast cancer choosing double mastectomy may be influenced 
by media coverage of celebrities (Sabel & Dal Cin, 2016). 
The BRCA mutations genetic test is not performed for every woman that is 
at risk of developing breast cancer; it is usually recommended by physicians for 
women of a younger age who may be at risk for developing breast cancer, or who 
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have several family members diagnosed with breast cancer. BRCA mutation testing 
is a very expensive test that can cost up to $3000 (Park, 2013) and insurance 
companies require that patients meet a threshold for needing the BRCA test before 
they consider covering its cost.  
Despite knowing that CPM does not improve survival rate, many women with 
unilateral breast cancer are choosing this procedure in order to ease their fear and 
potentially extend their lives (Rosenberg et al., 2013). Rosenberg et al. (2013) suggested 
that evidence-based decision-making interventions are needed in order to improve risk 
communication. Several factors can affect the decision-making process of women 
with unilateral breast cancer to undergo a CPM, but to what extent was the decision, 
of a woman with unilateral breast cancer to have CPM influenced by the partner, 
physician, and media? There are several reasons for the increased rate in CPM, but few 
studies have examined the influence of partner, physician and the media on the decision-
making process of women with unilateral breast cancer to undergo CPM. Breast cancer 
patients can be influenced by others and may not be making informed decision about 
engaging in this aggressive and irreversible procedure. Breast cancer patients should 
understand the benefits versus the risks of CPM in order to make informed decisions. 
This study is needed because the findings of the study could highlight the need for 
developing a decision quality tool that helps women with early stage unilateral breast 
cancer make informed decisions regarding their surgical choices and address an existing 
gap in the literature. The decision quality tool can be a brochure that includes but is not 
limited to the indication for the CPM procedure, the necessity and the medically 
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unnecessary indication of the procedure, doctor’s recommendation, the pro and cons of 
the procedure, the complications, and frequently asked questions, as well as feedback 
from patients who did and did not choose CPM. The patient should have good knowledge 
regarding the irreversible procedure so they can make a shared informed decision about 
their treatment options. 
Purpose of the Study 
 The purpose of this study was to assess the influence of the partner, physician, 
and media on the decision of women with unilateral breast cancer who decided to 
undergo CPM. The independent variables are the influence of partner, physician, and 
media; the dependent variable is the decision to undergo CPM. 
Research Questions and Hypotheses 
The research questions and hypotheses for this study were as follows: 
Research Question 1: To what extent is the decision of a woman with unilateral    
breast cancer to have CPM influenced by partners? 
H01: Partners have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H11: Partners have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 2: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by physicians? 
H02: Physicians have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
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H12: Physicians have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 3: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by the media? 
H03: The media has no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H13: The media has a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Theoretical Framework 
 The decision theory was used as a theoretical framework to identify the impact of 
physician, partner and media on the decision-making process of breast cancer women to 
undergo CPM, as well as whether these women made the decision on their own, only by 
the physician; or whether the women and physicians exchanged information and 
preferences and made the decision together. By using the theoretical framework, the 
results of the study might move beyond the original questions and framework and might 
add something new to the body of the research. 
Normative and Descriptive Decision Theories 
 The decision theory is founded on the connection between the rational preferences 
with certain structural properties (Buchak, 2013). The components of these theorems can 
be interpreted in different ways. Philosophy's interest in decision theory represents a 
union between two different lines of thought; one is centered around the question on how 
individuals ought to act, while the other is concerned with the action related to the actor’s 
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mental states (Buchak, 2013). As a result, philosophy has adopted this theory in two 
different uses, the normative use and the interpretive use.  The subject of decision making 
has been active in psychological inquiry since the beginning of experimental psychology 
(Patel & Kaufman, 2002). Decision making research traces back to the 1940s and 50s 
(Patel et al., 2002). It was first inspired by Van Neumann and Morgenstern's theory of 
games (Patel et al., 2002). Social scientists in several different disciplines started to 
advance the systematic study of decision making and developed abstract theoretical 
models and conducted empirical studies (Patel et al., 2002). Other social science 
disciplines, including economics, business, psychology, sociology, and political science, 
dedicated significant effort in applying these models and refining them in order to 
investigate different phenomena and develop related applications (Patel et al., 2002).  
  The normative theories of decision making are based on two main types of 
models: the expected utility (EU) and the subjective expected utility (SEU; Patel et al., 
2002). The idea behind these two models is that when making a decision, "one should 
maximize one's gain" (Patel et al., 2002, p. 55).The second type of model uses the notion 
of conditional probability as expressed "in the subjectivist, personalist, or Bayesian 
perspective" (Patel et al., 2002, p. 55). The aspects of these types of models are that they 
lay the standards of comparing and improving actual human decision-making and provide 
well defined mathematical models of rational decisions (Patel et al., 2002). 
Shared Model of Decision-Making 
The shared model of decision-making is the derivative of the normative decision 
theory. It integrates the feature that patients are consumers of medical care and have the 
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right to actively participate in the decision-making process concerning treatment choices 
and risk reduction strategies (Elwyn et al., 2012). Shared decision-making (SDM) has 
been defined as an approach in which physicians and patients jointly decide which 
medical treatment option is best based on current evidence and patient’s preferences, 
needs, and values (Elwyn et al., 2012). The normative decision theory includes an active 
attempt in order to engage patient’s values in the decision-making process. In order to 
accomplish this goal, patients are provided with decision aids such as informative 
brochures, videos, computer programs, as well as physician’s inputs (Elwyn et al., 2012). 
This model is conceptualized as providing the patient with both objective medical 
information incorporated with their subjective values and opinions (Elwyn et al., 2012). 
Nature of the Study 
 A quantitative cross-sectional survey design was used for this research. The 
survey design provided a numeric description (see Creswell, 2009) of the factors that are 
affecting the women decision to undergo CPM; as well as the influence of the partner, 
physician, and the media, on the woman’s decision-making process. The survey for this 
study consisted of 16 questions that were adopted and modified from the Prophylactic 
Mastectomy Outcomes Study Survey (Geiger et al., 2006). Women with stage 0 to III 
early stage unilateral breast cancer ages 20-60 years old who underwent CPM at MD 
Anderson Cancer Center between January of 2010 and December of 2017 were the target 
population for this study. Excluded from the study were women who (a) had bilateral 
breast cancer before undergoing CPM; (b) had received any treatment for breast cancer 
before their initial visit to MD Anderson; (d) had bilateral breast cancer before 
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undergoing CPM; and (e) had incomplete documentation of diagnosis of breast cancer, 
hormone receptor status or metastatic disease were excluded from the study. The 
independent variables were the influence of partner, physician, and media; the dependent 
variable was the decision to undergo CPM. Descriptive statistics were used to analyze the 
characteristics of the patients, and binary outcomes modeled by logistic regression 
(binomial distribution with logit link) was used in order to assess the influence of doctors, 
partners and media on patient’s decision to have CPM.  For each outcome, inclusion of 
potential covariates was assessed by adding them to the model and comparing them to the 
model without the covariate based upon the Akaike Information Criteria (AIC); models 
including a covariate which did not improve (lower) the AIC with relation to the 
intercept-only model, implicitly showing no evidence of significant association between 
the outcome and that covariate. 
Definition of Terms 
      The American Cancer Society website was used to define the following cancer-
related terms (American Cancer Society, 2014). 
Advanced Cancer/metastasis: "a general term describing stages of cancer in 
which the disease has spread from where it started (the primary site) to other parts of the 
body" (American Cancer Society, 2014, para. 27). 
AJCC Staging System: "American Joint Committee on staging system (also called 
the TNM system), which is used to describe the extent of spread of many types of cancer, 
typically with the number 0 (zero) and Roman numerals I through IV" (American Cancer 
Society, 2014, para. 17). 
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Atypia: "not normal; refers to the appearance of cancerous or pre-cancerous cells 
under the microscope" (American Cancer Society, 2014, para. 70). 
Bilateral: "on both right and left sides of the body" (American Cancer Society, 
2014, para. 12). 
Body image: "the way a person thinks about their body and how they think it 
looks to others" (American Cancer Society, 2014, para. 24). 
BRCA1: "a gene which, when damaged (mutated), puts a person at a higher risk 
of developing breast, ovarian, and some other types of cancer when compared to people 
who do not have this mutation"(American Cancer Society, 2014, para. 35).  
BRCA2: "a gene which, when damaged (mutated), puts a person at a higher risk 
of developing breast, ovarian, and some other types of cancer when compared to people 
who do not have this mutation" (American Cancer Society, 2014, para. 36). 
Breast Cancer: "cancer that starts in the breast. The most common types of cancer 
are ductal carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma, 
medullary carcinoma, and Paget disease of the nipple. Lobular carcinoma in situ is 
sometimes listed as non-invasive type of cancer, even though it is not a true cancer or 
pre-cancer" (American Cancer Society, 2014, para. 39). 
Breast implant: "a sac used to increase the breast size or restore the shape of a 
breast after mastectomy (surgical removal of the breast). The sac is filled with silicone 




Breast Self-Exam (BSE): "a way to check your own breasts for lumps or 
suspicious changes" (American Cancer Society, 2014, para. 43). 
Cancer: "a group of diseases which cause cells in the body to change and grow 
out of control. Most types of cancer cells from a lump or mass called a tumor" (American 
Cancer Society, 2014, para. 5). 
Cancer cell: "a cell that divides and reproduces abnormally and can spread 
throughout the body, crowding out normal cells and tissue. Cancer cells develop because 
of damage to their deoxyribonucleic acid (DNA)" (American Cancer Society, 2014, para. 
7). 
Carcinoma in situ: "an early stage of cancer in which the cancer cells are only in 
the layer of cells where they first began, and have not grown into nearby tissues in other 
parts of the organ or spread to distant parts of the body" (American Cancer Society, 2014, 
par AJCC Staging System a. 20). 
Decision quality tool: The decision quality tool can be a brochure that includes 
but not limited to the indication for the CPM procedure, the necessity and the medically 
unnecessary indication of the procedure, doctor’s recommendation, the pro and cons of 
the procedure, the complications, and frequently asked questions, as well as feedbacks 
from patients who did and did not choose CPM. The patient should have good knowledge 
regarding the irreversible procedure so they can make a shared informed decision about 
their treatment options. 
Fibrosis: "formation of scar-like tissues" (American Cancer Society, 2014). 
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Invasive ductal carcinoma: "a cancer that starts in the milk passages (ducts) of the 
breast and then breaks through the duct wall, where it grows into the fatty tissue of the 
breast. at this point, it can spread elsewhere. It is the most common type of breast cancer, 
accounting for about 80% of all invasive breast cancers" (American Cancer Society, 
2014). 
Invasive lobular carcinoma: "a cancer that starts in the milk-producing glands 
(lobules) of the breast and then breaks through the lobule walls and grows into the nearby 
fatty tissue. From there, it may spread elsewhere. About 1 in 10 invasive breast cancers 
are invasive lobular carcinomas. This type of cancer can be hard to detect by 
mammogram" (American Cancer Society, 2014). 
Mammogram: "an x-ray of the breast; a method of finding breast cancer that can't 
be felt using the fingers" (American Cancer Society, 2014). 
Mastectomy: "surgery to remove all or part of the breast and sometimes other 
tissue" (American Cancer Society, 2014). 
Papilloma: "benign growth that extends out from a surface, such as wart" 
(American Cancer Society, 2014). 
Prophylactic mastectomy: "is a mastectomy done before any evidence of cancer 
can be found, for the purpose of preventing cancer" (American Cancer Society, 2014). 
Margin: "in cancer surgery or biopsy, the tissue beyond the visible edge of the 
tumor or abnormal tissue that is removed along with the tumor or abnormality, in an 




     This study helped identify the factors as well as the influence partner, physician, 
and media on the decision-making process of women with unilateral breast cancer to 
undergo a CPM. The following were the assumptions that were considered: 
 The concern about breast cancer recurrence is one of the main factors that are 
driving the decision of women with unilateral breast cancer to undergo CPM.  
 Surgeons could be influencing women with unilateral breast cancer to undergo 
CPM. 
 Partners could be influencing women with unilateral breast cancer to undergo 
CPM. 
 The media could influence women with unilateral breast cancer to make this 
drastic surgical decision to undergo CPM. 
 Because I used a survey to conduct my research study, I assumed that the patients 
would answer the questions truthfully. The consent that patients signed before answering 
the survey questions assured them that their anonymity and confidentiality was preserved 
and that they can withdraw from the study at any time with no ramifications. I also 
assumed that the sample that I chose was representative of the population I wanted to 
make inferences about. The assumption was the research provided a basis in order to 
develop theories as well as research instruments.  
Scope and Delimitations 
 The women for the research study were identified from an existing cohort of 
breast cancer patients’ age 20-60 years old, who were diagnosed with unilateral breast 
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cancer stage 0 to III, who had no clinical or radiographic evidence of contralateral breast 
cancer, and who underwent CPM between January of 2010 and December of 2017 at MD 
Anderson Cancer Center. Women who had bilateral breast cancer before undergoing 
CPM, received any treatment for breast cancer before their initial visit to MD Anderson, 
bilateral breast cancer before undergoing CPM, and patients with  incomplete 
documentation of diagnosis of breast cancer, hormone receptor status or metastatic 
disease were excluded from the study. Based on the survey answers, I was able to 
identify who influenced the women to make their decision to undergo CPM and their 
satisfaction with their decision. Age diversity among participants created a better 
understanding of the different age group decision making process. The purpose of the 
time frame between January of 2010 and December of 2017 was to give time to the 
participants to cope with their decision-making process and have a clearer and unbiased 
answer to the survey questions. The results of my study may be valuable to other breast 
cancer treatment institutions with respect to their recommendations on the use of CPM 
for their own patients that are diagnosed with unilateral breast cancer. The shared model 
of decision making can be used in this kind of study since it is the derivative of the 
normative decision theory. The theory integrates the feature that patients are consumers 
of medical care and have the right to actively participate in the decision-making process 
concerning treatment choices and risk reduction strategies. I used the normative model 
because it helps in breaking complex problems down into component parts, which 
reduces the cognitive workloads; and link choices to norms external to decision problems 
in order to ensure rational choices (Brennan, 1995). The normative decision theory 
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helped promote patient satisfaction in three major ways: (a) it provided structures that 
helped patients understand and clarify decision problems and make choices based on their 
rationales and personal values; (b) it also helped providers to explicitly consider the 
patients' values and preferences in the process of making treatment recommendations, 
which increased the likelihood of the patient satisfaction with the treatment or plan of 
care; and (c) it supported the implementation of guidelines thank blended the  multiple 
dimensions of patient satisfaction into a single, integrated judgment (Brennan, 1995).  
Limitations 
 One possible limitation to my study was that the patients that were evaluated for  
my study are inherent to one single institution, which might affect the external validity or 
the generalizability of the study findings. The response bias might be the only bias that 
might affect my research; the breast cancer patients can consciously or unconsciously 
give responses that they think that the person conducting the research might want to see. 
The major methodological strength of this study was that all women who met criteria for 
the study received an e-mail to complete the survey; a larger sample size could lead to 
more reliable results.  In order to address the response bias limitation, clear language was 
used in the survey to avoid a need for clarification to certain questions. The questions’ 
words and phrases were chosen with care and the questions were not framed in a way that 
I would most likely get the answer I wanted to hear. Also, the amount of options were not 
confusing and I communicated why and how I was conducting this survey in the 




 There are several factors that can affect the decision-making process of women 
with unilateral breast cancer to undergo a CPM. Some of the major factors are women 
younger than 50 years old, being White, a family history of breast cancer, BRCA1 and 
BRCA2 mutation testing, and the use of reconstruction as well as the genetic testing (Yi 
et al., 2010). Breast cancer patients should understand both the benefits and risks of CPM 
in order to make informed decisions. The patient decision should be influenced by 
knowledge; both their own and the information provided by their oncologist. Tutle et al. 
(2007) discussed the controversy of whether a physician should initiate a discussion 
about CPM when a patient could be treated with lumpectomy or unilateral mastectomy. 
Breast cancer patients can experience much stress around the time they are first 
diagnosed and may need to decide in a very short period of time; this decision about 
double mastectomy is irreversible (Tutle et al., 2007). Breast cancer patients should have 
more information about their disease and the treatment options and should be more 
involved in decisions about their care. Physicians should incorporate patient's values in 
the treatment decision. Patients may wish to undergo a process of shared decision-making 
with their provider to reach a final decision (Elwyn et al., 2012). 
 The purpose of this study was to assess the influence of the partner, physician, 
and media on the decision of women with unilateral breast cancer who decided to 
undergo CPM. The potential contribution of the study, to advance practice and promote 
positive social change, was that it could help in assessing the influence of the partner, 
physician, and media on the decision of women with unilateral breast cancer who decided 
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to undergo CPM. The findings could highlight the need of decision aids programs or 
tools that help breast cancer women increase their knowledge of their treatment options, 
reduce their decisional conflicts, and make informed decisions that align with their goals 
and values.  
 It is important for women with unilateral breast cancer to fully understand the 
benefits versus the adverse effects of CPM and make an informed decision regarding the 
irreversible surgical procedure. The starting point is the focus on improving the informed 
decision-making process (Rosenberg, & Partridge, 2014). Evidence-driven models are 
needed to better inform women about their risk of contralateral breast cancer in order to 
empower them in their active decision-making process (Yi et al., 2009). 
Summary 
 Even though the CPM can be efficacious, the decision of a woman with unilateral 
breast cancer to undergo this irreversible procedure is substantial and requires that the 
patient weigh the risks and the benefits with their individual values before they make 
their final decision. The woman's role in the decision-making process to undergo CPM is 
still unclear. Information from this study may help in assessing the influence of the 
partner, physician, and media on the decision of women with unilateral breast cancer who 
decided to undergo CPM. Chapter 2 will discuss the current literature, literature search 
strategies, the theoretical framework, and critically evaluate the different studies that 
have been conducted and focused on CPM. 
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Chapter 2: Literature Review 
 
Contralateral Prophylactic Mastectomy (CPM) is a procedure that women with 
unilateral breast cancer may choose because they believe it might prevent breast cancer in 
the healthy breast. The trend of the increasing rate of CPM among women with unilateral 
breast cancer has raised concern, particularly with the lack of evidence for a survival 
benefit related to the CPM procedure (Tracy, Rosenberg, Dominici, & Partridge, 2013), 
and with the minimal (0.5%-0.75%) annual risk of women with early stage sporadic 
breast cancer for developing contralateral breast cancer (Brewster & Parker, 2011). 
Women might be choosing this procedure to ease their fear of recurrence, and by 
believing that CPM may improve their quality of life; others might be influenced by their 
physicians, partners, or even the media. Despite knowing that CPM does not improve 
survival rate, many women with unilateral breast cancer are choosing this procedure in 
order to ease their fear and potentially extend their lives (Rosenberg et al., 2013). There 
are various reasons for the increase in CPM rates, but few studies have examined the 
influence of partner, physician, as well as the media, on the women's decision-making 
process. The purpose of this study was to identify the factors that affect the decision-
making process of women who underwent CPM; and to what extent the decision, of a 
woman with unilateral breast cancer to have CPM was influenced by the partner, 
physician, and media. This chapter will include a discussion of the current literature, 
literature search strategies, the theoretical framework, and critically evaluate the different 




Literature Search Strategy 
I performed literature searches within several databases including PubMed, 
ACSO, NCBIMA, and ProQuest, as well as within online dissertations available at 
Walden University. Keyword combinations included: prophylactic mastectomy, breast 
cancer screening, risk factors, risk reduction, decision making, surveillance, genetic 
testing, BRCA, and quality of life. Thirty three articles that pertained to breast cancer and 
prophylactic mastectomies had distinctive gaps in the amount of information related to 
the influence of partner, physician, and media on the decision-making process of women 
with unilateral breast cancer who decided to undergo a high risk, irreversible prophylactic 
mastectomy in the healthy breast. For each journal article, a review of the abstracts was 
performed first, before a full-text study was reviewed. Several criteria were developed in 
order to narrow the focus of the search due to the availability of hundreds of studies 
related to prophylactic mastectomy. Studies were prioritized by eliminating studies that 
were performed before 2007. The articles that were not peer- reviewed were also 
eliminated, as well as the studies in which women were diagnosed with stage IV breast 
cancer and/or had clinical or radiographic evidence of contralateral breast cancer. Articles 
that involved women diagnosed with unilateral breast cancer stage 0 to III, who had no 





Decision Science and Normative Decision Theory 
 Decision science claims its roots in economics, psychology, mathematics, and 
probability (Brennan, 1995). There are two recognized divisions of the decision theory: 
behavioral and normative (Brennan, 1995). Behavioral decision theory confirms that 
when the human’s information-processing skills face a complex task, it will deteriorate, 
especially when judging uncertain situations (Brennan, 1995). The normative decision 
theory proposes ways "to compensate for the limitations of human information 
processing" (Brennan, 1995, p. 252). The normative models help in breaking complex 
problems down into component parts, which reduces the cognitive workloads and links 
choices "to norms external to decision problems" (Brennan, 1995, p. 252) in order to 
ensure rational choices. The normative decision theory helps promote patient satisfaction 
in major ways. First, it provides structures that help patients understand and clarify 
decision problems and make choices based on their rationales and personal values. 
Second, it can also help providers to explicitly consider patient values and preferences in 
the process of making treatment recommendations, which could increase patient 
satisfaction with the treatment or plan of care and support the implementation of 
guidelines that blend the multiple dimensions of patient satisfaction into a single, 
integrated judgment (Brennan, 1995).  
 Normative decision theory suggests that an individual’s decision is made by 
unbiased, logical and measured assessment of the advantages and disadvantages 
surrounding a choice. Specifying criteria or evaluating standards for decision making is 
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what constitute a good decision (Patel et al., 2002). Rationale decision-making is the 
framing assumption of the normative decision (Patel et al., 2002). The normative models 
of the physician-patient relationship in the treatment decision-making process have been 
used, developed and advocated in several studies (Szasz & Hollander, 1956; Veatch, 
1972; Quill, 1983; Emanuel & Emanuel, 1992; Deber, 1994). 
Shared Model of Decision Making 
 The shared model of decision making is a derivative of the normative decision 
theory and was used in my research study as a theoretical framework. It integrates the 
feature that patients are consumers of medical care and have the right to actively 
participate in the decision-making process concerning treatment choices and risk 
reduction strategies. The normative decision theory includes an active attempt in order to 
engage patient values in the decision-making process. In order to accomplish this goal, 
patients are provided with decision aids such as informative brochures, videos, computer 
programs, as well as physicians’ inputs. This model is conceptualized as providing the 
patient with both objective medical information incorporated with subjective values and 
opinions (Elwyn et al., 2012). The term shared decision making (SDM) was first 
introduced in a report entitled “President’s Commission for The Study of Ethical 
Problems in Medicine and Biomedical Research" (AHRQ, 1998). This report focused on 
increasing interest in patient-centredness and on increasing the patient's autonomy in 
healthcare interaction since 1970s (AHRQ, 1998). Referring to a Consumer Bill of 
Rights, this report stated: 
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Consumers have the right and responsibility to fully participate in all decisions 
related to their health care. Consumers who are unable to fully participate in 
treatment decisions have the right to be represented by parents, guardians, family 
members, or other conservators. Physicians and other health professionals should: 
provide patients with sufficient information and opportunity to decide among 
treatment options consistent with the informed consent process; discuss all 
treatment options with a patient in a culturally competent manner, including the 
option of no treatment at all; ensure that persons with disabilities have effective 
communications with members of the health system in making such decisions; 
discuss all current treatments a consumer may be undergoing; discuss all risks, 
benefits, and consequences to treatment or non-treatment; give patients the 
opportunity to refuse treatment and to express preferences about future treatment 
decisions; discuss the use of advance directives -- both living wills and durable 
powers of attorney for health care -- with patients and their designated family 
members; abide by the decisions made by their patients and/or their designated 
representatives consistent with the informed consent process. Health plans, 
providers, and facilities should: disclose to consumers factors -- such as methods 
of compensation, ownership of or interest in health care facilities, or matters of 
conscience -- that could influence advice or treatment decisions; assure that 
provider contracts do not contain any so-called "gag clauses" or other contractual 
mechanisms that restrict health care providers' ability to communicate with and 
advise patients about medically necessary treatment options; be prohibited from 
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penalizing or seeking retribution against health care professionals or other health 
workers for advocating on behalf of their patients (AHRQ, 1998, p.1). 
Achieving SDM depends on building a good relationship between the physician 
and the patients in the clinical encounter in order for the information to be shared with the 
breast cancer patients and that the patients are supported to express and deliberate their 
preferences regarding their treatment options during the decision making process (Elwyn 
et al., 2012). The patient’s decision should not only be influenced by a partner, physician, 
or the media. It should play an active role in making an informed decision regarding the 
treatment options. (SDM) has been defined as an approach in which physicians and 
patients jointly decide which medical treatment option is best based on current evidence 
and patient’s preferences, needs and values (Elwyn et al., 2012). Patients' decision can be 
compromised and affected by the disease or the stressful situations, such as the new 
diagnosis of breast cancer. For this reason, patients should be provided with tools and 
education that help them make an informed decision.  
Breast Cancer 
Risk Factors 
 Breast cancer is a disease that affects one in eight women during their lifetime 
(NIH, 2013a). It is the second leading cause of death in women after lung cancer (NIH, 
2013a). It is not well understood why some women are affected with breast cancer more 
than others, but there are some risk factors that could be the cause of breast cancer. Some 
of these risk factors include age, genes (BRAC1 and BRAC2), personal factors, such as 
women who begin their menstrual cycle before the age of 12 or go through menopause 
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after age 55, being overweight, hormone replacement therapy, birth control pills, 
consuming high amount of alcohol, not having the first child before the age of 35, or 
having dense breasts (NIH, 2013a). Symptoms of breast cancer can differ from one 
woman to another. These symptoms include a lump in the breast, changes in the shape 
and size of the breast, and/or nipple discharge (NIH, 2013a). Breast cancer may be found 
early through a self-breast exam, mammography, and/or clinical breast exam. If found 
early, there is better chance for breast cancer to be successfully treated (ACS, 2014). 
Treatment may consist of lumpectomy, mastectomy, chemotherapy, radiation, and/or 
hormonal therapy. Women who are at a very high risk of developing breast cancer may 
undergo a prophylactic mastectomy. In addition, the women who are diagnosed with 
breast cancer and have high risk of developing breast cancer in the healthy breast may 
consider CPM. Traditionally, CPM was performed on women with unilateral breast 
cancer with mutations in the BRAC genes (Jin, 2013, p. 1548) but in recent years more 
women with unilateral breast cancer who lack mutations are also undergoing CPM (Jin, 
2013, p. 1548). 
Breast Cancer Screening 
The American Cancer Society’s recommendations regarding breast cancer 
screenings are: 
 Women aged 40 years and older should have a mammogram yearly and  
 
should continue to do so for as long as they are in good health (ACS, 2014). 
 
 Women in their 20s should start Breast Self-Exam (BSE). They should be  
 




SBE. Any changes in their breast should be reported immediately to their health  
 
professional (ACS, 2014). 
 
 Women in their 20s and 30s should have a clinical breast exam (CBE) as part of a 
periodic (regular) health exam by a health professional preferably every 3 years. 
Starting at age 40, women should have a CBE by a health professional every year 
(ACS, 2014). 
 Women who are at high risk (greater than 20% lifetime risk) for breast cancer 
based on certain factors should get an MRI and a mammogram every year. 
Women who are at moderate risk (15% to 20% lifetime risk) should talk to their 
health professional regarding the benefits and limitations of adding MRI 
screening to their yearly mammogram. Yearly MRI screening is not 
recommended for women who are at a lifetime low risk (less than 15%) of 
developing breast cancer (ACS, 2014). Breast Cancer Risk Factors That Cannot 
Change Gender. Being a woman is one of the main risk factors for developing 
breast cancer. Men can also develop breast cancer but the disease much more 
common among women than men (ACS, 2014). This is due to the fact that men 
have less of the female hormones, estrogen and progesterone, which can promote 
the growth of breast cancer cells (ACS, 2014).  
 Aging. Age is another risk factor for developing breast cancer. The risk of 
developing breast cancer increases as individuals get older (ACS, 2014). About 1 
out of 8 invasive breast cancers are found in women younger than 45, and 2 of 3 
invasive breast cancer are found in women age 55 and older (ACS, 2014). 
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 Genetic risk factors. Breast cancer can be hereditary; the American Cancer 
Society believes that 5% to 10% of breast cancer cases are thought to be 
hereditary (ACS, 2014), which is caused by inheriting gene defects/ mutations 
from a parent. Inherited BRCA1 and BRCA2 are the most common cause of 
hereditary breast cancer (ACS, 2014). In normal cells, BRCA1 and BRCA2 genes 
prevent cancer by making proteins that help keep the cells from growing 
abnormally (ACS, 2014); an inherited mutated copy of either gene from a parent, 
can result in a higher risk of developing breast cancer during a lifetime. Women 
who inherited these mutations are at high risk of developing breast cancer at a 
younger age and these mutations more often affect both breasts than cancers not 
linked to these mutations (ACS, 2014). Women with inherited BRCA1 and 
BRCA2 gene mutations are also at high risk of developing other cancers, and 
particularly ovarian cancer (ACS, 2014).  
There are also changes in other genes that can put the women at a high risk of 
developing breast cancer, these gene mutations are rare but can cause inherited breast 
cancer as well (ACS, 2014). The following list defines various gene changes: 
 ATM: The normal function of the ATM genes is to help repair damaged DNA 
(ACS, 2014); but inheriting one abnormal copy of the ATM gene can link to a 
high rate of breast cancer in some families (ACS, 2014, p.3). 
 TP53: the role of this gene is to give instructions for making P53 protein that 
helps stop the growth of abnormal cells (ACS, 2014). Inherited P53 mutations 
29 
 
cause Li-Fraumeni syndrome. People who have the Li-Fraumeni syndrome have a 
higher risk of developing breast cancer as well as other types of cancer.  
 CHEK2: the Li-Fraumeni syndrome can also be caused by inherited CHEK2 gene 
mutations, when mutated it can increase breast cancer risk about two-fold (ACS, 
2014, p.3).  
There are also other gene mutations like PTEN, CDH1, and STK11 that increase the risk 
of developing breast cancer (ACS, 2014).  
Additional Risk Factors 
 Beyond biological and genetic factors found to influence developing breast cancer 
are other variables also have been found to resulting in enhanced risk.  These factors 
include family history, race and ethnic, dense breast tissue, certain benign breast 
conditions, lobular carcinoma in situ (LCIS), early starting or late ending menstrual 
periods, previous chest radiation in women, and diethylstilbestrol (DES) exposure. In this 
section, I describe each of these factors. 
Family history of breast cancer. Women that have close blood relatives who 
have breast cancer are at higher risk of developing this disease (ACS, 2014). Having a 
first-degree relative like mother, sister or daughter with breast cancer doubles the 
woman’s risk for developing this disease (ACS, 2014) having more than one first-degree 
relative with this disease can increase the woman’s risk about tree fold (ACS, 2014).  
Race and ethnicity. Caucasian women are more likely to develop breast cancer 
than African American women, but African American Women are more likely to die 
from this disease (ACS, 2014).  African American women 45 years of age and younger, 
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are more prone to have breast cancer (ACS, 2014). Native American, Hispanic, and 
Asian women are at lower risk of developing breast cancer.  
Dense breast tissue. Several factors can affect breast density; some of these 
factors are age, genetics, hormonal therapy for menopause, and menopausal status. 
Women with dense breast tissues are at higher risk for developing breast cancer, when 
compared to women with less dense breast (ACS, 2014).  
Certain benign breast conditions. Women who are diagnosed with certain 
benign breast conditions are at higher risk of developing breast cancer (ACS, 2014). The 
benign breast conditions are often divided into three groups; non-proliferative lesions 
(fibrosis, adenosis, non-sclerosing, mild hyperplasia, benign phyllodes tumor, single 
papilloma, fat necrosis, duct ectasia, periductal fibrosis, squamous and apocrine 
metaplasia, infection of the breast, and other benign tumors), proliferative lesions without 
atypia (ductal hyperplasia without atypia, adenosis, papilloma, or scar), and proliferative 
lesions with atypia (ductal hyperplasia (ADH), and lobular hyperplasia (ALH)) (ACS, 
2014). 
Lobular carcinoma in situ (LCIS). In LCIS, “cells that look like cancer cells are 
growing in the lobules of the milk-producing glands of the breast, but they do not grow 
through the wall of the lobules” (ACS, 2014, p.7). Women with LCIS are 7 to 11 times 
more prone to develop breast cancer in either breast (ACS, 2014). 
Menstrual periods. According to the American Cancer Society (2014), women 
who had their first menstrual cycles before the age of 12 and/or went through menopause 
after age 55 are at higher risk of developing breast cancer. The increase in risk is due to 
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the fact that these women are more exposed during their lifetime to the hormones 
estrogen and progesterone (ACS, 2014). 
Previous chest radiation, women. Who at a younger age were treated with 
radiation therapy to the chest due to another type of cancer like Hodgkin disease or non-
Hodgkin lymphoma, are at higher risk of developing breast cancer. The younger (during 
adolescence) the woman was when she received chest radiation the higher the risk of 
developing breast cancer; this is due to the fact that the breasts were still developing 
(ACS, 2014). Radiation treatment after the age of 40 did not seem to increase the risk of 
breast cancer (ACS, 2014).   
Diethylstilbestrol (DES) exposure. DES was an estrogen-like drug that was 
given to women from the 1940s through the early 1970s in order to lower their chances of 
miscarriage (ACS, 2014). These women have a slightly increased risk of developing 
breast cancer (ACS, 2014). In addition, women whose mothers took DES during 
pregnancy have a slightly higher risk of developing breast cancer (ACS, 2014).  
Prophylactic Mastectomy on the Rise for Breast Cancer.  
Many women who are diagnosed with unilateral breast cancer are choosing to 
undergo CPM in order to prevent breast cancer in the healthy breast. The rate of CPM in 
the United States has more than doubled from 1.8% in 1998 to 4.5 % in 2003 (Tuttle et 
al., 2007). The trend of increasing the rate of CPM among women with unilateral breast 
cancer has raised concern, especially with the lack of evidence for a survival benefit 
related to the CPM procedure (Tracy et al., 2013).  Women may be choosing this 
procedure in order to ease their fears of recurrence. These women may also believe that 
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CPM may improve their quality of life. Tuttle et al. (2007) noted that CPM is another 
way to prevent breast cancer in the healthy breast; this procedure is on the rise, but is it 
really necessary? The rationale of CPM comes from the premise that women who are 
diagnosed with unilateral breast cancer have a better chance to survive the primary breast 
tumor, that the treatment used for the index cancer might leave the women with unilateral 
breast cancer at significant risk of developing contralateral breast cancer (CBC), and that 
CBC will compromise their survival (Khan, 2011). Two different population-based 
studies showed that in women first diagnosed with breast cancer before the age of 50, all 
CBC occurred at the annual rate of 0.1%, and for the same age group but with HR-
negative first breast tumor, the rate was 0.2% (Kurian et al., 2009; Bouchardy et al., 
2010). For women diagnosed with breast cancer after the age of 50 at first diagnosis, the 
CBC rate was even lower (Kurian et al., 2009). The second study showed that the overall 
rate of CBC is 0.3% per year; when the first breast tumor was HR-negative, the rate was 
0.25%, whereas when the tumor was HR-positive, the rate was 0.65% (Bouchardy et al., 
2010).  The data from these two studies revealed that the risk of developing CBC is 
higher for women with an HR-negative first primary breast cancer. Thus, three different 
studies confirmed that HR negativity still did not emerge as a selection factor for CBC 
(Stucky et al., 2010; Arrington et al., 2009; King et al., 2011). Boughey et al. (2010) 
found that there is a non-significant breast cancer-specific survival advantage for CPM. 
The effectiveness of CPM in reducing breast cancer mortality is still unclear. 
Tuttle et al. (2007) suggested that further studies are critically needed in order to evaluate 
the patients’ decision-making process that is leading them to consider CPM, and to 
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understand the decision-making process behind this aggressive breast cancer surgery. 
Brewster and Parker (2011) also noted that the CPM rate in the U.S. among women with 
unilateral invasive breast cancer increased by 150% from 1993 to 2003; patients might 
overestimate the benefits of CPM and others may underestimate the severity of some of 
the side effects associated with this procedure. It is important for women with unilateral 
breast cancer to fully understand the benefits as well as the side effects that are associated 
with CPM in order to make informed and supported decisions, based on accurate 
understanding of the pros versus the cons of the procedure.  
Efficacy of CPM 
Prophylactic mastectomy can reduce the risk of breast cancer in women with 
strong family history of breast cancer, who have a mutation in the BRCA1 gene or 
BRCA2 gene, or who have other breast cancer associated mutations in other genes, such 
as TP53 and PTEN (NCI, 2013b). However prophylactic mastectomy is not considered 
an appropriate cancer prevention option for women who had breast cancer in one breast 
but are not at the highest risk of developing cancer in the healthy breast; such women 
may however consider the use of certain drugs to reduce their risk (NCI, 2013b). The risk 
of developing another breast cancer in the same breast or the contralateral breast is very 
small, especially if women receive adjuvant chemotherapy or hormone therapy as part of 
their cancer treatment (NCI, 2013b). Despite knowing that CPM does not improve 
survival rate, many women with unilateral breast cancer are choosing this procedure in 
order to ease their fear and extend their lives (Rosenberg et al., 2013). Rosenberg et al. 
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(2013) suggested that evidence-based decision-making interventions are needed in order 
to improve risk communication.  
Factors Associated with CPM Decision-Making 
Yi et al. (2010) were able to identify different factors that were associated with 
the decision-making process of women with unilateral breast cancer undergoing CPM. 
The major factors identified were women younger than 50 years old, white ethnicity, a 
family history of breast cancer, BRCA1 and BRCA2 mutation testing, and the use of 
reconstruction as well as the genetic testing. Women were not always informed of their 
absolute risk of developing contralateral breast cancer as well as the risk of recurrence 
from the primary breast cancer; Yi et al. (2010) suggested that evidence-driven models 
are needed to help women in their active decision-making process. Jones et al. (2009) 
also showed that women who are choosing to have CPM were younger, more highly 
educated, and more likely to have a family history of cancer (p. 2696). King et al. (2011) 
tried to determine in their study whether the increased rate of CPM was related to the 
recognition of risk factors for contralateral breast cancer or treatment factors related to 
the index lesion. The result of their study showed that the increased use of CPM was not 
associated with the increase recognition of the breast cancer patients who are at high risk 
for CBC. Treatment factors such as MRI, immediate reconstruction, and unsuccessful 
breast conservation attempts were associated with the increased rates of CPM (King et 
al., 2011). King et al. (2011) also suggested that patient education is needed in order to 
decrease the rates of unnecessary tests and optimize breast conservation.  
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Physicians Influence on CPM Decision Making Process 
 A breast cancer diagnosis can carry with it a fear of death, depression, and severe 
anxiety. The timing for these psychological factors could not be worse, as the women 
who are diagnosed with breast cancer must make complicated treatment decisions and 
pass through different treatment regimens. A significant number of women who are 
diagnosed with breast cancer choose to undergo CPM in order to reduce the risk of 
contralateral breast cancer (CBC; Yi et al., 2010). The decision-making process between 
surgeons and patients is complicated (Yi et al., 2010). The patient- physician relationship 
should shift from a traditional paternalistic model and in which all the decisions are made 
primarily by the physician to one in which patients are informed of their health care, 
risks, benefits, and treatment options and should participate in the decision-making 
process (Nekhlyudov et al., 2005). This approach is also known as "informed decision-
making". In this process the patient knows the risks, and benefits of her disease and 
treatment options, and engages in the decision-making, or "shared decision making" 
(Nekhlyudov et al., 2005, p.55). Patient involvement is important since the effect of the 
decision may be substantial (Nekhlyudov et al., 2005). Assessing the patients for CBC 
risks, tumor histology, and multicentricity are key elements in the decision-making 
process. There are also other issues to consider which include reconstruction surgeries, 
and the ability to achieve symmetry if a patient only considers unilateral mastectomy and 




Katz and Morrow, in their article entitled "Contralateral Prophylactic Mastectomy 
for Breast Cancer Addressing Peace of Mind" (Katz & Morrow, 2013) believed that 
surgeons are not always clear about why they perform CPM for low risk women with 
unilateral breast cancer, and that they are increasingly uncomfortable with performing 
more extensive, irreversible surgeries that may be associated with additional morbidity 
and complications. The majority of these patients are prone to overtreatment, especially 
since the insurance companies cover CPM regardless of risk of secondary breast cancer, 
and reinforce the notion that CPM is clinically indicated; it also facilitates the patient 
self-referral to a surgeon who is willing to perform this procedure (Katz & Morrow, 
2013). Katz and Morrow (2013) suggested that clinical indications for CPM are needed 
before the insurance companies provide coverage to patients; by doing so, the factors that 
may affect surgeons to address overtreatment will be reduced. Abbott et al. (2011) 
highlighted an important issue regarding CPM in their study and suggested that early 
physician counseling is needed in order to provide breast cancer patients with accurate 
information regarding their true contralateral breast cancer (CBC) risk. They also noticed 
that the rate of CPM is increasing; they decided to study and assess the perceptions of 
CBC risk among breast cancer women and to evaluate the risk factors associated with the 
risk perception. They concluded that the perceived risk of CBC was not associated with 
the cancer stage, family history, age, or CPM;  that women with UBC, and at time of 
surgical evaluation overestimate their risk of CBC; however, this elevated risk perception 
was not associated with choosing CPM (Abbott et al., 2011).  
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Brewster and Parkers (2011) in their study “Current Knowledge on Contralateral 
Prophylactic Mastectomy among Women with Sporadic Breast Cancer” discussed the 
issue of the lack of information regarding the clinical value of CPM among breast cancer 
patients with sporadic breast cancer, and acknowledged the fact that there is an increase 
in the numbers of CPM in the United States among patients with unilateral invasive 
breast cancer between 1993 and 2003 (150% increase). They also discussed the 
conflicted evidence about whether CPM can reduce breast cancer mortality rates or 
overall death.  They noted that there are gaps in knowledge regarding the clinical value of 
CPM including patient and physician related psychosocial factors that influence the 
decision-making process of breast cancer women with sporadic breast cancer to undergo 
CPM (Brewster, & Parker, 2011). NCI (2007) highlighted the importance for breast 
cancer patients to be aware of the higher risk of systemic metastases from unilateral 
breast cancer that exceeds the risk of contralateral breast cancer and that most patients 
will not experience any survival benefits from CPM (NCI, 2007). Komen (2012) 
provided information about the National Comprehensive Cancer Network (NCCN) 
guidelines that are discouraging women to consider CPM to lower their incidence of 
getting breast cancer in their healthy breast, and recommending that this procedure 
should only take place if women are considered at high risk of breast cancer which 
include patients who carry a BRAC1 or BRAC2 mutation or those with Li-Fraumeni 
Syndromes (Komen, 2012).  
Preventative medicine is usually encouraged by physicians and by the media but 
choosing to remove both breasts in order to prevent breast cancer in the healthy breast 
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seems to be growing increasingly common (Breast Cancer, 2013). There is limited data in 
the literature characterizing the influence of physicians, partners, and the media on the 
decision-making process of women with unilateral breast cancer to undergo CPM. 
Celebrities Influence on CPM Decision Making Process 
 The media may use celebrities’ spokespersons in public health and marketing 
industries in order to influence the public about an issue or a new product. Spokespeople 
have more opportunities to influence behavior because the public is exposed more than 
ever to media messages (Shimp, 2007).  Media’s reports regarding celebrities’ decision 
concerning the risk of developing breast cancer present bias toward CPM. This may say 
breast cancer patients’ opinion about CPM, particularly when factors such as risk and 
genetic are excluded (Sabel, 2016).    
Summary and Conclusions 
 When faced with life threatening diseases like breast cancer, patients might make 
uninformed decisions regarding their treatment. They might also overestimate the 
benefits of CPM and others may underestimate the severity of some of the side effects 
associated with this procedure. It is important for women with unilateral breast cancer to 
fully understand the benefits as well as the side effects that are associated with CPM in 
order to make informed and supported decisions, based on accurate understanding of the 
pros versus the cons of the procedure. Decision-making surrounding early diagnosis of 
breast cancer, with respect to CPM option, and by using a shared decision-making 
approach, gives patients and physicians the opportunity to jointly decide which medical 
treatment option is best based on current evidence and patient’s preferences, needs and 
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values (Rosenberg, & Partridge, 2014). A clinical educational instrument is important to 
help women with unilateral breast cancer make informed decision regarding CPM, and to 
improve the quality of life of breast cancer survivors. Chapter 3 will describe the research 
design, methodology, data collection, and data analysis used in the research. Studies 
covered the various reasons for the increase in CPM rates, but few studies have examined 





Chapter 3: Research Method 
Introduction 
The purpose of this study was to determine whether the decision made by women 
with unilateral breast cancer who underwent CPM was influenced by the physician, 
partner, or media, or whether it was a shared and informed decision made by the patient. 
This chapter describes the methods used in the proposed study in order to explore the 
influences of physicians, partners, and media on the decision-making process of women 
with unilateral breast cancer and who choose to undergo CPM. This chapter consists of 
seven sections which include: the research design, population and sample size, 
description of the study variables, instrumentation, data analysis, protection of patient 
information, and dissemination findings, and concludes with a summary.  
Research Design and Rationale 
I used a quantitative cross-sectional survey design. The survey design provided a 
description of the factors that affect a woman’s decision to undergo CPM as well as the 
influence of the partner, physician, and the media, on the woman’s decision-making 
process.  The advantage of using a quantitative design in this research study is that the 
researcher can use a survey to ask questions without revealing a point of view, which can 
reduce potential bias (Creswell, 2009). A disadvantage to the quantitative design used in 
this research is that I could not discover insights into the breast cancer patients' feelings 
about the topic. The independent variables are the influence of partner, physician, and 
media; the dependent variable is the decision to undergo CPM. Time and resource 
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constraints are some of the barriers that I faced throughout my dissertation; my research 
required many visits to the hospital library and the data collection office.  
Methodology 
Population  
  The women for the research study were identified from an existing cohort of 
breast cancer patients, age 20-60 years old, who were diagnosed with unilateral breast 
cancer stage 0 to III, who had no clinical or radiographic evidence of contralateral breast 
cancer, and who underwent CPM between January of 2010 and December of 2017 at MD 
Anderson Cancer Center; the overall number of women available to survey was 1341. I 
excluded from the study, women who had bilateral breast cancer before undergoing 
CPM, who had received any treatment for breast cancer before their initial visit to MD 
Anderson, women who had bilateral breast cancer before undergoing CPM and patients 
with incomplete documentation of diagnosis of breast cancer, hormone receptor status or 
metastatic disease.   
Sampling and Sampling Procedures 
Women were selected from the surgical breast cancer database at MD Anderson 
Cancer Center. The sample size was calculated by using the creative research systems. In 
order to determine the sample size for the study, a power analysis was conducted to 
determine what an optimal sample size was. Power refers to the probability that the test 
used in the study will find a significant statistical difference when this difference exists 
(UMICH, 2015) and that the null hypothesis can be rejected, when it should, thus voiding 
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a type II error. Power should be 0.8 or greater (805) in order to find a statistically 
significant difference when there is one (UMICH, 2015). 
The alpha for the test of this model was set at 0.05. In order to achieve power of 
0.80 and a medium effect size, a sample of 384 was required in order to detect differences 
in the research study. The sample size was calculated by using the creative research 
systems (Conservation Gateway, 2015); I used a confidence level of 95 and a confidence 
interval level of 5 and got the sample size of 384.  
Procedures for Recruitment, Participation, and Data Collection 
 Participants received a link to the survey using the Red Cap platform. The survey 
took approximately 15 minutes to complete. An informed consent was included on the 
first page of the survey. The survey allowed the participants for “no response “or “prefer 
not to respond” as an option for every survey question. The email invitation collector 
option was used as well in order to check if respondent has responded, opted out, or was 
bounced from the recipient section. After 2 days, a reminder email was sent to 
participants, and after 4 days, a second reminder email was sent to participants to remind 
them to complete the survey. No clinical data was collected for patients who did not 
consent to the survey.  
Instrumentation and Operationalization of Constructs 
The survey used in this research study included different sections that examined 
the preferences, knowledge, decision making, and experiences of women with breast 
cancer to have CPM; and in which participants had to check the one best answer to each 
of the questions. The survey consisted of 16 questions that were adopted and modified 
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from the "Prophylactic Mastectomy Outcomes Study Survey" (Geiger et al., 2006). The 
Prophylactic Mastectomy Outcomes Study Survey has been used in multiple studies 
(Nekhlyodov et al., 2005; Greene et al., 2006; Geiger et al., 2006a; Geiger et al., 2006b). 
The development of the original survey used in these studies listed above included expert 
and focus group review for validity and reliability (Nekhlyodov et al., 2005). "The 
instrument included the following domains: women’s roles in the CPM decision, past and 
current satisfaction with CPM, current concern about getting breast cancer again, and 
depressive symptoms, as well as patient characteristics including age, race/ethnicity, 
education, marital status, breast cancer stage at CPM, and current perception of general 
health" (Nekhlyodov et al., 2005).  
I used the modified Control Preference Scale in order to assess the women's 
decision-making process at the time of CPM.  The modified Control Preference Scale 
was developed based on a grounded theory of how patients with life- threatening diseases 
make their decisions (Nekhlyudov et al., 2005).The scale had been previously validated 
to assess preferences for as well as the experiences in the decision making process, and 
was modified for the use in mailed and/or telephone-administered surveys (Nekhlyudov 
et al., 2005). The scale assesses patient involvement in decision making.   Informed 
choice is where the patients seeks information and plays an active role in the decision-
making process. SDM is where the patient and the provider exchange information and 
preferences and make joint decision. The paternalistic approach is where the patient takes 
a passive role and the decision is made by the provider (Nekhlyudov et al., 2005). I also 
included when a decision is made by the partner or influenced by the media to fall under 
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the paternalistic approach. In order to measure between the dependent variable (decision 
making) and the independent variables (influence of partner, physician, and media on the 
decision making process of women with early stage unilateral breast cancer); the 
participants were asked to describe their decision about the CPM and were asked to 
choose all that applied from the following list:  
 I made the final decision to have surgery. 
 I made the final decision to have surgery after seriously considering my doctor's 
opinion. 
 My doctor and I shared responsibility for the final decision to have surgery. 
 My doctor made the final decision about my surgery, but seriously considered my 
opinion. 
 My doctor made the final decision about my surgery. 
 I made the final decision to have surgery after seriously considering my partner's 
opinion. 
 My partner made the final decision about my surgery. 
Regarding the media influence; patients were asked to choose a number to indicate 
whether or not the media had influenced their decision making to undergo CPM with 
number one being not at all to number five being very much. Table 1 depicts the variable 






Table 1  





In order to assess the influence of doctors, partners, or media on patients’ decision 
to have a CPM performed, four binary outcome variables were defined: Doctor-
influenced versus self-choice [implying that the patient had checked at least one of the 
“doctor” related influence statements on the survey (doctor-influenced) versus having 
checked the “I made the final decision to have surgery” but none of the doctor-influenced 
statements (self-choice)], Partner-influenced versus self-choice [implying that the patient 





Nominal To what extent is the 
decision, of a woman with 
unilateral breast cancer, to 
have CPM influenced by 
partners? 
1) the woman made the 
decision On Own, 
2) the woman made the 
decision after considering 
 the partner's opinion, 
3) the woman shared the 
decision with the partner, 
and 
4) the partner/doctor 
decided On Own. 
Physicians' 
influence on the 
decision-
making process 
Nominal To what extent is the 
decision, of a woman with 
unilateral breast cancer, to 
have CPM influenced by 
physicians? 
1) the woman made the 
decision On Own, 
2) the woman made the 
decision after considering 
the doctor’s opinion, 
3) the woman shared the 
decision with the doctor, 
and 






Ordinal Please choose one number 
to indicate whether or not 
the media had influenced 
the decision of woman with 
unilateral breast cancer to 
undergo prophylactic 
mastectomy. 
1) Not at All, 
2) A Little Bit, 
3) Somewhat, 
4) Quite a Bit, 





had checked at least one of the “partner” related influence statements on the survey 
(partner-influenced) versus having checked the “I made the final decision to have 
surgery” but none of the partner-influenced statements (self-choice), for patients who 
indicated the presence of partners under the Marital Status section of the survey], Media-
influenced versus self-choice [implying that the patient had checked at least one of the 
“media” related influence statements on the survey other than “Not At All” (media-
influenced) versus having checked the “I made the final decision to have surgery” but 
none of the media-influenced statements (self-choice)], Any-influence versus self-choice 
[implying that the patient had checked at least one of the doctor, partner, or media related 
influence statements on the survey as with the above variables].  Henceforth these binary 
variables will be referred to as simply doctor-influenced, partner-influenced, media-
influenced, and any-influenced.  
Incidence of each of the binary outcomes was modeled by logistic regression 
(binomial distribution with logit link).  For each outcome, inclusion of potential 
covariates was assessed by adding them to the model and comparing them to the model 
without the covariate based upon the Akaike Information Criteria (AIC); models 
including a covariate which did not improve (lower) the AIC with relation to the model 
without it implicitly show no evidence of significant association between the outcome 
and that covariate.  Potential covariates considered included the presence of family 
history of breast cancer, age category, race, marital status, presence of partner, education 
category, presence of estrogen or progesterone receptor, presence of lymphovascular 
invasion (LVI), whether the CPM was performed on a different versus the same day as 
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the definitive surgery, tumor grade, and pathology stage.  For the doctor-influenced and 
partner-influenced models, only the inclusion of the covariate for family history of breast 
cancer improved the model.   For the media influenced model, none of the covariates 
yielded improved models over the intercept-only model.  For the any-influence model, 
inclusion of the covariates for family history of breast cancer and pathology stage each 
improved the model and including both covariates yielded the most improved model.  
Further, inclusion of both of these variables in models for the other outcomes had little 
effect on the otherwise optimal model, so for consistency I will base final analysis 
summaries and figures on these two-covariate models.  Note that the covariates for 
marital status and presence of partner were excluded from consideration of inclusion in 
the partner-influenced and any-influenced model due to confounding with partner-
influence.  Differences among levels of variables with 3 or more levels were assessed by 
Tukey-adjusted contrasts. 
Additionally, for the sake of completion, fully-adjusted versions of the above 
models for each of the binary outcomes were produced, including the presence of 
covariates for family history of breast cancer, age category, race, presence of partner, 
education category, presence of estrogen or progesterone receptor, presence of 
lymphovascular invasion (LVI), whether the CPM was performed on a different versus 
the same day as the definitive surgery, tumor grade, and pathology stage, with the 
exception that the presence of partner was excluded from inclusion in the partner-
influenced and any-influenced model due to confounding with partner-influence.  These 
fully adjusted models had by far the highest AICs among the models considered for each 
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outcome, and were thus the worst among all models, plus may be subject to some lack of 
independence among the covariates. 
Statistical analyses were performed using R statistical software (R Core Team, 2019, 
version 3.6.1). In all statistical tests, two-sided alpha=.05.  Predictions and differences 
among factor levels in the logistic regression models were estimated using the 
“emmeans” package (Lenth 2018); this includes adjusted means weighted proportionally 
to covariate marginal frequencies.  Catseye plots (Cumming 2014) were produced using 
the “catseyes” package (Andersen 2019). 
 For Research Question 1 (Quantitative): To what extent is the decision, of a 
woman with unilateral breast cancer, to have CPM influenced by partners? 
Potential covariates considered included the presence of family history of breast cancer, 
age category, race, education category, presence of estrogen or progesterone receptor, 
presence of lymphovascular invasion (LVI), whether the CPM was performed on a 
different versus the same day as the definitive surgery, tumor grade, and pathology stage.  
For partner-influenced models, only the inclusion of the covariate for family history of 
breast cancer improved the model (p=0.014).    
 For Research Question 2 (Quantitative): To what extent is the decision, of a 
woman with unilateral breast cancer, to have CPM influenced by physicians? 
Potential covariates considered included the presence of family history of breast cancer, 
age category, race, presence of partner, education category, presence of estrogen or 
progesterone receptor, presence of lymphovascular invasion (LVI), whether the CPM was 
performed on a different versus the same day as the definitive surgery, tumor grade, and 
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pathology stage.  For the doctor-influenced models, only the inclusion of the covariate for 
family history of breast cancer improved the model (p=0.041).   
 For Research Question 3 (Quantitative): To what extent is the decision, of a 
woman with unilateral breast cancer, to have CPM influenced by the media? 
Potential covariates considered included the presence of family history of breast cancer, 
age category, race, presence of partner, education category, presence of estrogen or 
progesterone receptor, presence of lymphovascular invasion (LVI), whether the CPM was 
performed on a different versus the same day as the definitive surgery, tumor grade, and 
pathology stage.  For the media-influenced models, only the inclusion of the covariate for 
pathological stage (II-0) improved the model (p=0.022).   
The research questions that guided this study were: 
The research questions and hypotheses for this study were as follows: 
Research Question 1: To what extent is the decision of a woman with unilateral    
breast cancer to have CPM influenced by partners? 
H01: Partners have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H11: Partners have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 2: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by physicians? 
H02: Physicians have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
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H12: Physicians have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 3: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by the media? 
H03: The media has no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H13: The media has a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
The independent variables were the influence of partner, physician, and media; 
the dependent variable was the decision to undergo CPM. The woman’s decision-making 
roles regarding CPM were divided into five categories: (a) the woman made the decision 
on her own, (b) the woman’s decision to undergo CPM was influenced by the physician, 
(c) the woman shared the decision with her physician, (d) the woman’s decision to 
undergo CPM was influenced by the partner, and (e) the woman’s decision to undergo 
CPM was influenced by the media. Potential covariates considered included the presence 
of family history of breast cancer, age category, race, presence of partner, education 
category, presence of estrogen or progesterone receptor, presence of lymphovascular 
invasion (LVI), whether the CPM was performed on a different versus the same day as 
the definitive surgery, tumor grade, and pathology stage.   
Threats to Validity 
 Experimental mortality and internal validity: there are several reasons why some 
patients might drop out of the research study. Some of these reasons are: death, no longer 
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willing to participate in the study, no longer available, and geographical move. The 
experimental mortality becomes a threat to internal validity when the number of dropouts 
is large, which can affect the sample size of the research study. Also, any factor that can 
affect the generalizability of the results will have a threat to external validity. Selection 
bias might be one of the factors that can have a threat to external validity since I was 
chose all the participants from only one cancer organization. When selection bias occurs, 
it is difficult to argue that the result might not be generalized to the wider population. 
Random irrelevancies in the experimental setting is a threat to the statistical conclusion 
validity since the patients that are answering the survey questions in this specific cancer 
facility might have a different experience than patients in different settings/facilities. 
Ethical Procedures 
 MD Anderson, Breast Oncology Research department was contacted regarding the 
study. MD Anderson Institutional Review Board (IRB# PA18-0378) is the IRB of record for 
the research study and permission was obtained to contact the patients that meet the inclusion 
criteria of the study via e-mail. An informed consent was included on the first page of the 
survey. Since I emailed the survey questions using the Red Cap to participants, issues 
such as privacy can become a threat because of the use of the internet/ computer-based 
method to answer the survey questions. The use of technology might inappropriately 
limit the sample. Also, for patients who have had a mastectomy, completing a survey 
about their experience could trigger some unpleasant memories. Participants were 
reminded on the survey that their participation was voluntary. Patient’s confidentiality 
was assured. The information gathered by each individual patient was used as part of a 
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larger statistical analysis. Patients were not harmed because data from individual patients 
were de-identified. Participants’ data were stored in the principal investigator’s computer, 
which was password protected. After study termination, data and identifiers were handled 
per applicable institutional policies. No adverse impacts were expected on rights or 
welfare of the subject because confidentiality was protected. Identifiers (name, medical 
record number, email address, location) were collected but were replaced by coded study 
numbers in the analytic file. Data will be destroyed after a 5-year period.  
Summary 
Three hundred eighty-four women with stage 0 to III early stage unilateral breast 
cancer age 20-60 years old who underwent CPM at the cancer center between January of 
2010 and December of 2017 were the target population for this quantitative study which 
used a cross-sectional survey design. Descriptive statistics was used to analyze the 
characteristics of the patients, and binary outcomes modeled by logistic regression 
(binomial distribution with logit link) was used in order to assess the influence of doctors, 
partners and media on patient’s decision to have CPM.  For each outcome, inclusion of 
potential covariates was assessed by adding them to the model and comparing them to the 
model without the covariate based upon the Akaike Information Criteria (AIC); models 
including a covariate which did not improve (lower) the AIC with relation to the 
intercept-only model implicitly show no evidence of significant association between the 





Chapter 4: Results 
Introduction 
The purpose of this study was to assess the influence of the physician, partner, 
and media on women’s decision making with regards to the utilization of CPM among 
women with early stage unilateral breast cancer and to determine to what extent their 
decision was influenced by their physician, partner, and media.  The research questions 
and hypotheses for this study were as follows: 
The research questions and hypotheses for this study were as follows: 
Research Question 1: To what extent is the decision of a woman with unilateral    
breast cancer to have CPM influenced by partners? 
H01: Partners have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H11: Partners have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 2: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by physicians? 
H02: Physicians have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H12: Physicians have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 3: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by the media? 
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H03: The media has no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H13: The media has a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
In Chapter 4, I describe the data collection process including the time frame, the response 
rates, the discrepancies in the data collection, the characteristic of the sample, validity, 
and inclusion criteria and variables. It will also discuss the challenges and the adverse 
events faced during the survey process, and the results of the analysis. 
Data Collection 
Using the prospectively maintained Breast Cancer Database Management System 
housed in the Department of Breast Medical Oncology at MDACC, I identified 1341 
women with a diagnosis of early-stage (stage 0-III), breast cancer who underwent CPM 
between January of 2010 and December of 2017 at MDACC with no clinical or 
radiographic evidence of contralateral breast cancer. The database was developed and 
maintained prospectively in line with stringent quality controls and its structure is very 
similar to the national comprehensive cancer network (NCCN) database to which there 
has been major contributions over the last 2 decades. To avoid selection bias, I included 
those who had received their initial treatment and subsequent surveillance visits at 
MDACC and excluded those who had presented only for an initial consultation or a 
second opinion (see Sinha et al., 2017). I  reviewed the electronic medical records of 
these women and extracted data on demographic characteristics, including ethnicity/race, 
family history of breast in first- and second-degree relatives, BRCA status, tumor 
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characteristics, including tumor stage, biomarkers and grade and treatment received (type 
of surgery, radiotherapy, and endocrine therapy). Patients self-reported their race at the 
time of registration. Following the inclusion criteria, all the patients were aged 20 to 60 
years at diagnosis. I excluded patients who had received any treatment for breast cancer 
before their initial visit to MD Anderson, women who had bilateral breast cancer before 
undergoing CPM and patients with incomplete documentation of diagnosis of breast 
cancer, hormone receptor status or metastatic disease. Also excluded were individuals 
incapable or unwilling to sign the informed consent.  
The tumor stage was determined using the seventh edition of the American Joint 
Committee on Cancer guidelines (Edge & Compton, 2010). Biomarkers of tumors were 
those that were either estrogen receptor positive or negative (ER + or ER-) or 
progesterone receptor positive or negative (PR + or PR -) as determined by 
immunohistochemistry using institutional cutoffs. Human epidermal receptor (HER2) 
status was assessed by immunohistochemistry or fluorescence in situ hybridization when 
available and determined as positive or negative on the basis of institutional cutoffs and 
guidelines that were current at the time of diagnosis (Wolff et al., 2013).  
This study was conducted under MD Anderson Institutional Review Board 
(#PA18-0378), and an informed consent was obtained from all participants. All the 
women who met the criteria of the sampling from the database at the Cancer Center were 
asked to complete the survey. The survey included different sections that examined the 
preferences, knowledge, decision making, and experiences of women with breast cancer 
to have CPM. Participants had to check the one best answer to each of the questions. The 
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survey consisted of 16 questions that were adopted and modified from the "Prophylactic 
Mastectomy Outcomes Study Survey." The instrument includes the following domains: 
women’s roles in the CPM decision, satisfaction with CPM, current concern about getting 
breast cancer again, and depressive symptoms, as well as patient characteristics including 
age, race/ethnicity, education, marital status, breast cancer stage at CPM, and current 
perception of general health" (Geiger et al., 2006).  
Survey data were collected and managed using REDCap electronic data capture 
tools hosted at MD Anderson cancer center (Harris et al., 2009). REDCap (Research 
Electronic Data Capture) is a secure, web-based application designed to support data 
capture for research studies, providing: 1) an intuitive interface for validated data entry; 
2) audit trails for tracking data manipulation and export procedures; 3) automated export 
procedures for seamless data downloads to common statistical packages; and 4) 
procedures for importing data from external sources. 
Results 
Descriptive Statistics 
Descriptive statistics were performed on the women who were enrolled in the 
study. Following are the results of the analysis related to age, race, education, and marital 
status.  





Age of women who underwent CPM 
Age Group Counts Frequency 
20 to 30 10 2.80% 
31 to 40  91 25.20% 
41 to 50  161 44.60% 
51 to 60  99 27.40% 
Total 361 100% 
 
Table 3 illustrates the results of the descriptive analysis related to Race. 
Table 3 
Race of women who underwent CPM 
Age Group Counts Frequency 
Asian or Pacific Islander 13 3.6% 
Black or African American  15 4.2% 
Hispanic, Latino  40 11.1% 
Native American or Alaskan 
















Table 4 illustrates the results of the descriptive analysis related to the level of education. 
Table 4 
Highest level of education of women who underwent CPM 
Education Level Counts  Frequency  
Less than or some high school 0 0% 
High school or GED 29 8.1% 
Trade or technical school 13 3.6% 
Junior college or some college 64 17.9% 
College graduate 132 36.9% 
Post graduate work or degree 120 33.5% 
Total 358 100% 
 
Table 5 illustrates the results of the frequency analysis related to the marital status. 
 
Table 5 
Marital status of women who underwent CPM 
Marital status Counts  Frequency 
Married 305 81.8% 
Lived together but not married 12 3.2% 
Separated or divorced  28 7.5% 
Widowed 10 2.7% 
Never married 18 4.8% 





Table 6 illustrates the results of the frequency analysis related to women’s concern. 
Table 6 
Concern level of women who underwent CPM 
Concern levels Counts Frequency 
Very concerned 135 36.4% 
Concerned 73 19.7% 
Not very concerned  78 21.0% 
Not concerned at all 85 22.9% 
Total 371 100% 
 
Three research questions guided this study: 
The research questions and hypotheses for this study were as follows: 
Research Question 1: To what extent is the decision of a woman with unilateral    
breast cancer to have CPM influenced by partners? 
H01: Partners have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H11: Partners have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 2: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by physicians? 
H02: Physicians have no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
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H12: Physicians have a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
Research Question 3: To what extent is the decision of a woman with unilateral  
breast cancer to have CPM influenced by the media? 
H03: The media has no significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
H13: The media has a significant influence on the decision-making process of 
women with unilateral breast cancer to undergo CPM.  
.  
The decision-making process and the effect of physician, partner, and media, the 
percentages were calculated using the relative frequency of the responses to the questions 
(n = 372). Table 7 illustrates the percentages of the relative frequency analysis related to 
the decision-making process and the effect of physician, partner, and media, on the 















Decision-making process and the effect of physician, partner and media of women who underwent CPM 
Decision Counts  Frequency 
I made the final decision to have surgery 201 54% 
I made the final decision to have surgery after seriously considering my 
doctor's opinion.  
165 44.4% 
My doctor and I shared responsibility for the final decision to have surgery.  60 16.1% 
My doctor made the final decision about my surgery, but seriously considered 
my opinion.   
2 0.5% 
My doctor made the final decision about my surgery.  4 1.1% 
I made the final decision to have surgery after seriously considering my 
partner's opinion.  
59 15.9% 































The probability of doctor-influenced CPM decision per logistic regression is  
 
illustrated in figure 1; the overall probability is shown at left, followed by separate 
probabilities based upon family history of breast cancer at right.  The distribution of the 
model-adjusted means is illustrated by catseye plots with shaded +/- standard error and 
have been transformed from the logit scale to the probability scale such that distributions 
near 0% or 100% are asymmetrically distorted accordingly. 
 
 
Figure 1. Probability of Doctor-Influenced CPM Decision per Logistic Regression 
 
 
The probability of partner-influenced CPM decision per logistic regression is illustrated 
in figure 2. The overall probability is shown at left, followed by separate probabilities 
based upon family history of breast cancer at right.  The distribution of the model-
adjusted means is illustrated by catseye plots with shaded +/- standard error and have 
been transformed from the logit scale to the probability scale such that distributions near 
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0% or 100% are asymmetrically distorted accordingly.  The shaded horizontal line 
indicates 50% probability. 
 




The probability of media-influenced CPM decision per logistic regression is illustrated in 
figure 3. The distribution of the model-adjusted mean is illustrated by catseye plot with 
shaded +/- standard error and has been transformed from the logit scale to the probability 
scale such that distributions near 0% or 100% are asymmetrically distorted accordingly.  





Figure 3. Probability of Media-Influenced CPM Decision per Logistic Regression.   
 
 
The probability of any influenced CPM decision per logistic regression is illustrated in 
figure 4. The overall probability is shown at left, followed by separate probabilities based 
upon family history of breast cancer at right.  The distribution of the model-adjusted 
means is illustrated by catseye plots with shaded +/- standard error and have been 
transformed from the logit scale to the probability scale such that distributions near 0% or 






Figure 4. Probability of Any-Influenced CPM Decision per Logistic Regression. 
 
In order to assess the influence of doctors, partners, or media on patients’ decision 
to have a CPM performed, four binary outcome variables were defined: Doctor-
influenced versus self-choice [implying that the patient had checked at least one of the 
“doctor” related influence statements on the survey (doctor-influenced) versus having 
checked the “I made the final decision to have surgery” but none of the doctor-influenced 
statements (self-choice)]; Partner-influenced versus self-choice [implying that the patient 
had checked at least one of the “partner” related influence statements on the survey 
(partner-influenced) versus having checked the “I made the final decision to have 
surgery” but none of the partner-influenced statements (self-choice), for patients who 
indicated the presence of partners under the Marital Status section of the survey]; Media-
influenced versus self-choice [implying that the patient had checked at least one of the 
“media” related influence statements on the survey other than “Not At All” (media-
influenced) versus having checked the “I made the final decision to have surgery” but 
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none of the media-influenced statements (self-choice)]; Any-influence versus self-choice 
[implying that the patient had checked at least one of the doctor, partner, or media related 
influence statements on the survey as with the above variables].  Henceforth these binary 
variables will be referred to as simply doctor-influenced, partner-influenced, media-
influenced, and any-influenced.  
Incidence of each of the binary outcomes was modeled by logistic regression 
(binomial distribution with logit link).  For each outcome, inclusion of potential 
covariates was assessed by adding them to the model and comparing them to the model 
without the covariate based upon the Akaike Information Criteria (AIC); models 
including a covariate which did not improve (lower) the AIC with relation to the model 
without it implicitly show no evidence of significant association between the outcome 
and that covariate.  Potential covariates considered included the presence of family 
history of breast cancer, age category, race, marital status, presence of partner, education 
category, presence of estrogen or progesterone receptor, presence of lymphovascular 
invasion (LVI), whether the CPM was performed on a different versus the same day as 
the definitive surgery, tumor grade, and pathology stage.  For the doctor-influenced and 
partner-influenced models, only the inclusion of the covariate for family history of breast 
cancer improved the model.   For the media influenced model, none of the covariates 
yielded improved models over the intercept-only model.  For the any-influence model, 
inclusion of the covariates for family history of breast cancer and pathology stage each 
improved the model and including both covariates yielded the most improved model.  
Further, inclusion of both of these variables in models for the other outcomes had little 
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effect on the otherwise optimal model, so for consistency I will base final analysis 
summaries and figures on these two-covariate models.  Note that the covariates for 
marital status and presence of partner were excluded from consideration of inclusion in 
the partner-influenced and any-influenced model due to confounding with partner-
influence.  Differences among levels of variables with 3 or more levels were assessed by 
Tukey-adjusted contrasts. 
Additionally, for the sake of completion, fully-adjusted versions of the above 
models for each of the binary outcomes were produced, including the presence of 
covariates for family history of breast cancer, age category, race, presence of partner, 
education category, presence of estrogen or progesterone receptor, presence of 
lymphovascular invasion (LVI), whether the CPM was performed on a different versus 
the same day as the definitive surgery, tumor grade, and pathology stage, with the 
exception that the presence of partner was excluded from inclusion in the partner-
influenced and any-influenced model due to confounding with partner-influence.  These 
fully adjusted models had by far the highest AICs among the models considered for each 
outcome, and were thus the worst among all models, plus may be subject to some lack of 
independence among the covariates. 
Statistical analyses were performed using R statistical software (R Core Team, 
2019, version 3.6.1). In all statistical tests, two-sided alpha=.05.  Predictions and 
differences among factor levels in the logistic regression models were estimated using the 
“emmeans” package (Lenth 2018); this includes adjusted means weighted proportionally 
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to covariate marginal frequencies.  Catseye plots (Cumming 2014) were produced using 
the “catseyes” package (Andersen 2019). 
Overall, 203/343 patients reported some doctor influence on the CPM decision.  
The logistic regression model of the incidence of doctor-influence demonstrated 
significantly higher overall influence on the CPM decision due to doctors compared to 
self-determination alone (p=.0006), suggesting that 59% of patients’ decisions were 
influenced by doctors.  The model also showed that patients with a family history of 
breast cancer had significantly higher odds of doctor-influence than those without 
(p=.029). There was no evidence of association with pathology stage. These results are 
summarized in table 8. 
Table 8 
 
Logistic Regression Model Summary for Incidence of Doctor-Influence.  
 Adj. 
Mean 
SE Probability CI95Min CI95Max p-value 
Overall 0.38 0.11 0.59 0.54 0.65 0.0005 
Overall probability of doctor Influence     
 
 
Difference due to family history of breast cancer 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 














Difference due to pathology stage (note that these are Tukey-adjusted p –values). The overall 
Type III p=0.27 

















































Overall, 53/189 patients with partners reported some partner influence on the 
CPM decision.  The logistic regression model of the incidence of partner-influence 
demonstrated significantly lower overall influence on the CPM decision due to partners 
compared with self-determination alone (p<.0001, same with Hommel adjustment), 
suggesting that 27% of patients’ decisions were influenced by partners.  The model also 
showed that patients with a family history of breast cancer had significantly higher odds 
of partner-influence than those without (p=.0015). There was no evidence of association 
with pathology stage. These results are summarized in table 9. 
Table 9 
 
 Logistic Regression Model Summary for Incidence of Partner-Influence. 
 Adj. 
Mean 
SE Probability CI95Min CI95Max p-value 
Overall -.99 0.17 0.27 0.21 0.34 <.0001 
Overall probability of partner influence 
           
Difference due to family history of breast cancer 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 





Difference due to pathology stage (note that these are Tukey-adjusted p –values). The overall 
Type III p=0.46 

















































Overall, 36/213 patients reported some level of media influence on the CPM 
decision.  The logistic regression model of the incidence of media-influence 
demonstrated significantly lower overall influence on the CPM decision due to media 
compared with self-determination alone (p<.0001), suggesting that 16% of patients’ 
decisions were influenced by media. The model also showed that patients with a family 
history of breast cancer trended higher in incidence of association with media influence, 
but this trend lacked evidence of significance (p=.59). There was no evidence of 











Logistic Regression Model Summary for Incidence of Media-Influence. 
 Adj. 
Mean 
SE Probability CI95Min CI95Max p-value 
Overall -1.68 0.20 0.16 0.11 0.22 <.0001 
Overall probability of media influence       
 
Difference due to family history of breast cancer 
  Adj. 
Mean 
SE OddsRatio CI95Min CI95Max p-value 
Overall 0.21 0.38 1.23 0.59 2.58 <.059 
Overall probability of media influence 
 
Difference due to pathology stage (note that these are Tukey-adjusted p –values). The overall 
Type III p=0.08 

















































Overall, 224/332 patients reported some level of any influence on the CPM 
decision.  The logistic regression model of the incidence of any-influence demonstrated 
significantly higher overall influence on the CPM decision due to any-influence 
compared with self-determination alone (p<.0001), suggesting that 68% of patients’ 
decisions were influenced by some combination of doctor, partner, or media. The model 
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also showed that patients with a family history of breast cancer had significantly higher 
odds of any-influence than those without (p=.040). Additionally, this model showed 
evidence that patients with lower pathology stage tended to have higher probability of 
any-influence on their decision, and a trend of declining influence with higher stage.  
These results are summarized in table 11. 
Table 11 
 
Logistic Regression Model Summary for Incidence of Any-Influence. 
 Adj. 
Mean 
SE Probability CI95Min CI95Max p-value Hommel 
p-value 
Overall .75 0.12 0.68 0.63 0.73 <.0001 <0.0001 
Overall probability of any influence 
           
Difference due to family history of breast cancer 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value Hommel 
p-value 
True - False 0.50 0.24 1.64 1.02 2.64 0.040 0.040 
 























DecisionDoctorVsSelf FamHis, Age,Race,Partner Education, Receptor, 
Lymphatic_Invasion, DiffDaySurg, Tumor Grade, PathStage 
Coefficients Estimate Std. Error p-value 
    (Intercept) -0.381 0.835 0.65 
 
FamHist (TRUE - FALSE) 0.490 0.239 *0.041 
 
Age (41 to 50 years old - 31 to 40 years old) 0.265 0.290 0.36 
 
Age (20 to 30 years old - 31 to 40 years old) 0.695 0.763 0.36 
 
Age (51 to 60 years old - 31 to 40 years old) 0.005 0.320 0.99 
 
Race (Hispanic/Latino - White or Caucasian) -0.577 0.381 0.13 
 
Race (Black or African American - White or Caucasian) -0.666 0.608 0.27 
 
Race (Asian or Pacific Islander - White or Caucasian) 0.040 0.612 0.95 
 
Race (Other - White or Caucasian) 0.139 0.761 0.86 
 
Partner (TRUE - FALSE) 0.309 0.331 0.35 
 
Education (Trade or technical school - High school or GED) 0.714 0.745 0.34 
 
Education (Junior college, or some college - High school or  
GED) 0.610 0.486 0.21 
 
Education (College graduate - High school or GED) 0.569 0.444 0.20 
 
Education (Postgraduate work or degree - High school or GED) 0.753 0.446 0.09 
 
Receptor (TRUE - FALSE) 0.261 0.311 0.40 
 
Lymphatic Invasion (POS - NEG) 0.184 0.283 0.51 
 
DiffDaySurg (TRUE - FALSE) -0.173 0.320 0.59 
 
TumorGrade (II - I) -0.270 0.500 0.59 
 
TumorGrade (III - I) 0.017 0.513 0.97 
 
PathStage (I - 0) -0.417 0.347 0.23 
 
PathStage (II - 0) -0.742 0.381 0.052 
 










DecisionPartnerVsSelf FamHis, Age,Race, Education, Receptor, Lymphatic_Invasion, 







(Intercept) -0.595 1.182 0.61 
 
FamHist (TRUE - FALSE) 0.884 0.359 *0.014 
 
Age (41 to 50 years old - 31 to 40 years old) -0.345 0.431 0.42 
 
Age (20 to 30 years old - 31 to 40 years old) 0.335 1.351 0.80 
 
Age (51 to 60 years old - 31 to 40 years old) -0.370 0.480 0.44 
 
Race (Hispanic/Latino - White or Caucasian) -0.122 0.558 0.83 
 
Race (Black or African American - White or Caucasian) 0.388 0.937 0.68 
 
Race (Asian or Pacific Islander - White or Caucasian) 0.327 0.816 0.69 
 
Race (Other - White or Caucasian) -15.787 1187.688 0.99 
 
Education (Trade or technical school - High school or GED) -0.138 1.115 0.90 
 
Education (Junior college, or some college - High school or GED) 0.559 0.752 0.46 
 
Education (College graduate - High school or GED) 0.239 0.692 0.73 
 
Education (Postgraduate work or degree - High school or GED) 0.235 0.711 0.74 
 
Receptor (TRUE - FALSE) 0.145 0.451 0.75 
 
Lymphatic Invasion (POS - NEG) 0.602 0.422 0.15 
 
DiffDaySurg (TRUE - FALSE) -0.623 0.512 0.22 
 
TumorGrade (II - I) -0.726 0.750 0.33 
 
TumorGrade (III - I) -0.591 0.772 0.44 
 
PathStage (I - 0) -0.068 0.480 0.89 
 
PathStage (II - 0) -0.892 0.583 0.13 
 








DecisionMediaVsSelf FamHis, Age,Race,Partner,  Education, Receptor, 







(Intercept) -0.497 1.440 0.73 
 
FamHist (TRUE - FALSE) 0.318 0.414 0.44 
 
Age (41 to 50 years old - 31 to 40 years old) -0.137 0.479 0.77 
 
Age (20 to 30 years old - 31 to 40 years old) 0.755 1.055 0.47 
 
Age (51 to 60 years old - 31 to 40 years old) -0.662 0.584 0.26 
 
Race (Hispanic/Latino - White or Caucasian) -0.374 0.690 0.59 
 
Race (Black or African American - White or Caucasian) 1.395 0.766 0.069 
 
Race (Asian or Pacific Islander - White or Caucasian) 0.693 0.814 0.39 
 
Race (Other - White or Caucasian) -14.595 1066.555 0.99 
 
Partner (TRUE - FALSE) 0.311 0.642 0.63 
 
Education (Trade or technical school - High school or GED) -0.039 1.435 0.98 
 
Education (Junior college, or some college - High school or GED) 0.845 0.943 0.37 
 
Education (College graduate - High school or GED) 0.810 0.865 0.35 
 
Education (Postgraduate work or degree - High school or GED) 0.500 0.885 0.57 
 
Receptor (TRUE - FALSE) -0.145 0.529 0.78 
 
Lymphatic Invasion (POS - NEG) 0.107 0.518 0.84 
 
DiffDaySurg (TRUE - FALSE) -0.217 0.614 0.72 
 
TumorGrade (II - I) -0.730 0.754 0.33 
 
TumorGrade (III - I) -1.521 0.819 0.063 
 
PathStage (I - 0) -0.824 0.528 0.12 
 
PathStage (II - 0) -1.552 0.675 *0.022 
 






DecisionAnyVsSelf FamHis, Age,Race,Partner,  Education, Receptor, 







(Intercept) 0.507 0.852 0.55 
 
FamHist (TRUE - FALSE) 0.519 0.258 *0.044 
 
Age (41 to 50 years old - 31 to 40 years old) 0.098 0.311 0.75 
 
Age (20 to 30 years old - 31 to 40 years old) 1.797 1.128 0.11 
 
Age (51 to 60 years old - 31 to 40 years old) -0.042 0.343 0.90 
 
Race (Hispanic/Latino - White or Caucasian) -0.403 0.414 0.33 
 
Race (Black or African American - White or Caucasian) 0.163 0.722 0.82 
 
Race (Asian or Pacific Islander - White or Caucasian) -0.270 0.622 0.66 
 
Race (Other - White or Caucasian) -0.138 0.763 0.86 
 
Education (Trade or technical school - High school or GED) 0.958 0.786 0.22 
 
Education (Junior college, or some college - High school or  
GED) 0.989 0.523 0.059 
 
Education (College graduate - High school or GED) 0.722 0.473 0.13 
 
Education (Postgraduate work or degree - High school or GED) 0.885 0.481 0.066 
 
Receptor (TRUE - FALSE) 0.297 0.341 0.38 
 
Lymphatic Invasion (POS - NEG) 0.092 0.298 0.76 
 
DiffDaySurg (TRUE - FALSE) -0.224 0.334 0.50 
 
TumorGrade (II - I) -0.063 0.525 0.91 
 
TumorGrade (III - I) 0.000 0.542 1.00 
 
PathStage (I - 0) -0.975 0.413 *0.018 
 
PathStage (II - 0) -1.235 0.451 *0.006 
 





Fully Adjusted Model: For each outcome, inclusion of potential covariates was 
assessed by adding them to the model and comparing them to the model without the 
covariate based upon the Akaike Information Criteria (AIC); models including a 
covariate which did not improve (lower) the AIC with relation to the intercept-only 
model implicitly show no evidence of significant association between the outcome and 
that covariate.  Potential covariates considered included the presence of family history of 
breast cancer, age category, race, marital status, presence of partner, education category, 
presence of estrogen or progesterone receptor, presence of lymphovascular invasion 
(LVI), and whether the CPM was performed on a different versus the same day as the 
definitive surgery.  Except for family history of breast cancer for the doctor-influenced, 
media-influenced, and any-influenced outcomes, inclusion of each of the covariates alone 
or in combination with family history resulted in a worsened model (higher AIC) 
compared to the intercept-only model.  Note that the covariates for marital status and 
presence of partner were excluded from inclusion in the partner-influenced and any-
influenced model due to confounding with partner-influence. The results of the adjusted 
models are illustrated in the tables below.  
Table 16 
 
Decision Doctor Vs Self Fully Adjusted Model Logistic Regression 
 for Family History 



















Decision Doctor Vs Self Fully Adjusted Model Differences due to Family History   
The overall Type III p=0.041 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 True - False 0.49 0.24 1.63 1.02 2.61 0.041 
 
For doctor versus self, inclusion of family history was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to family history was illustrated in table 16 and showed 
significant influence in the fully adjusted model of decision doctor versus self for patients 
with family history of breast cancer. 
Table 17 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Age 
Age Adj. 
Mean 
SE Probability CI95Min CI95Max 
31 to 40 years old 
 
41 to 50 years old 
 
20 to 30 years old 
 





































Decision Doctor Vs Self  Fully Adjusted Model Differences due to Age   











  41 to 50 years old-31 to 40 years old 
 
20 to 30 years old - 31 to 40 years old 
 
20 to 30 years old - 41 to 50 years old 
 
51 to 60 years old - 31 to 40 years old 
 
51 to 60 years old - 41 to 50 years old 
 







































For doctor versus self, inclusion of age was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to age was illustrated in table 17 and showed no 
significant influence in the fully adjusted model of decision doctor versus self despite the 
age range of the patients. 
Table 18 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Race 
Race Adj. 
Mean 
SE Probability CI95Min CI95Max 




Black or African American 
 
































Decision Doctor Vs Self  Fully Adjusted Model Differences due to Race  











Hispanic/Latino – White or Caucasian 
 
Black or African American – Hispanic/Latino 
 
Black or African American - Hispanic/Latino 
 
Asian or Pacific Islander - White or Caucasian 
 
Asian or Pacific Islander - Hispanic/Latino 
 
Asian or Pacific Islander - Black or African 
American 
 
Other - White or Caucasian 
 
Other - Hispanic/Latino 
 
Other - Black or African American 
 






























































For doctor versus self, inclusion of race was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to race was illustrated in table 18 and showed no 
significant influence in the fully adjusted model of decision doctor versus self despite the 
race of the patients. 
Table 19 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Partner 



















Decision Doctor Vs Self  Fully Adjusted Model Differences due to Partner  
The overall Type III p=0.35 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE 0.31 0.33 1.36 0.71 2.61 0.35 
 
 
For doctor versus self, inclusion of partner was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to partner was illustrated in table 19 and showed no 
significant influence in the fully adjusted model of decision doctor versus self despite 
whether the patient has a partner or not. 
Table 20 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Education 
Education Adj. 
Mean 
SE Probability CI95Min CI95Max 
High school or GED 
 
Trade or technical school 
 











































Decision Doctor Vs Self  Fully Adjusted Model Differences due to Education  











 Trade or technical school-High school, or GED 
 
Junior college, or some college-High school or GED 
 
Junior college, or some college-Trade or technical 
school 
 
College graduate-High school or GED 
 
College graduate-Trade or technical school 
 
College graduate-Junior college or some college 
 
Postgraduate work or degree-High school or GED 
 
Postgraduate work or degree-Trade or technical school 
 
Postgraduate work or degree-Junior college or some 
college 
 
































































For doctor versus self, inclusion of education was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to education was illustrated in table 20 and showed no 
significant influence in the fully adjusted model of decision doctor versus self despite the 
education levels of the patients. 
Table 21 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Receptor 




















Decision Doctor Vs Self  Fully Adjusted Model Differences due to Receptor  
The overall Type III p=0.40 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE 0.26 0.31 1.3 0.71 2.39 0.40 
 
For doctor versus self, inclusion of receptor was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to receptor was illustrated in table 21 and showed no 
significant influence in the fully adjusted model of decision doctor versus self despite the 
receptor status of the patients. 
Table 22 
 



















Decision Doctor Vs Self  Fully Adjusted Model Differences due to Lymphatic_Invasion  
The overall Type III p=0.51 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 POS-NEG 0.18 0.28 1.2 0.69 2.09 0.52 
 
For doctor versus self, inclusion of lymphatic invasion was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision doctor versus 
self, fully adjusted model differences due to lymphatic invasion was illustrated in table 22 
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and showed no significant influence in the fully adjusted model of decision doctor versus 
self despite the lymphatic invasion whether it is positive or negative. 
Table 23 
 
Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for DifDaySurg 
















Decision Doctor Vs Self  Fully Adjusted Model Differences due to DifDaySurg  
The overall Type III p=0.59 
Contrast Estimate SE Odds Ratio CI95Min CI95Max p-value 
 TRUE-FALSE -0.17 0.32 0.84 0.45 1.58 0.59 
 
For doctor versus self, inclusion of different day surgery was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision doctor versus 
self, fully adjusted model differences due to different day surgery was illustrated in table 
23 and showed no significant influence in the fully adjusted model of decision doctor 
versus self despite the choice of the patients to have CPM the same day of the surgery or  




Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Tumor Grade 
























Decision Doctor Vs Self  Fully Adjusted Model Differences due to Tumor Grade  
The overall Type III p=0.53 

























For doctor versus self, inclusion of tumor grade was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision doctor versus self, fully 
adjusted model differences due to tumor grade was illustrated in table 24 and showed no 




Decision Doctor Vs Self  Fully Adjusted Model Logistic Regression for Path Stage 







































Decision Doctor Vs Self  Fully Adjusted Model Differences due to Path Stage 
The overall Type III p=0.22 

















































For doctor versus self, inclusion of pathological stage was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision doctor versus 
self, fully adjusted model differences due to pathological stage was illustrated in table 25 
showed no significant influence in the fully adjusted model of decision doctor versus self 
despite the pathological stage of the tumor. 
Table 26 
 
Decision Partner Vs Self Fully Adjusted Model Logistic Regression 
 for Family History 















Decision Partner Vs Self  Fully Adjusted Model Differences due to Family History   
The overall Type III p=0.014 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 




For partner versus self, inclusion of family history was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to family history was illustrated in table 26 and showed 
significant influence in the fully adjusted model of decision partner versus self for 
patients with family history of breast cancer. 
Table 27 
 
Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Age 
Age Adj. 
Mean 
SE Probability CI95Min CI95Max 
31 to 40 years old 
 
41 to 50 years old 
 
20 to 30 years old 
 



























Decision Partner Vs Self  Fully Adjusted Model Differences due to Age   











  41 to 50 years old-31 to 40 years old 
 
20 to 30 years old - 31 to 40 years old 
 
20 to 30 years old - 41 to 50 years old 
 
51 to 60 years old - 31 to 40 years old 
 
51 to 60 years old - 41 to 50 years old 
 








































For partner versus self, inclusion of age was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to age was illustrated in table 27 and showed no 
significant influence in the fully adjusted model of decision partner versus self despite the 
age range of the patients. 
Table 28 
 
Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Race 
Race Adj. 
Mean 
SE Probability CI95Min CI95Max 




Black or African American 
 

































Decision Partner Vs Self  Fully Adjusted Model Differences due to Race  











Hispanic/Latino – White or Caucasian 
 
Black or African American – Hispanic/Latino 
 
Black or African American - Hispanic/Latino 
 
Asian or Pacific Islander - White or Caucasian 
 
Asian or Pacific Islander - Hispanic/Latino 
 
Asian or Pacific Islander - Black or African 
American 
 
Other - White or Caucasian 
 
Other - Hispanic/Latino 
 
Other - Black or African American 
 






























































For partner versus self, inclusion of race was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to race was illustrated in table 28 and showed no 
significant influence in the fully adjusted model of decision partner versus self despite the 











Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Education 
Education Adj. 
Mean 
SE Probability CI95Min CI95Max 
High school or GED 
 
Trade or technical school 
 
































Decision Partner Vs Self  Fully Adjusted Model Differences due to Education  











 Trade or technical school-High school, or GED 
 
Junior college, or some college-High school or GED 
 
Junior college, or some college-Trade or technical 
school 
 
College graduate-High school or GED 
 
College graduate-Trade or technical school 
 
College graduate-Junior college or some college 
 
Postgraduate work or degree-High school or GED 
 
Postgraduate work or degree-Trade or technical school 
 
Postgraduate work or degree-Junior college or some 
college 
 
































































For partner versus self, inclusion of education was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
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Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to education was illustrated in table 29 and showed no 
significant influence in the fully adjusted model of decision partner versus self despite the 
education levels of the patients. 
Table 30 
 
Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Receptor 
















Decision Partner Vs Self  Fully Adjusted Model Differences due to Receptor  
The overall Type III p=0.75 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE 0.14 0.45 1.16 0.48 2.8 0.75 
 
For partner versus self, inclusion of receptor was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to receptor was illustrated in table 30 and showed no 
significant influence in the fully adjusted model of decision partner versus self despite the 
































Decision Partner Vs Self  Fully Adjusted Model Differences due to Lymphatic_Invasion  
The overall Type III p=0.15 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 POS-NEG 0.6 0.42 1.83 0.8 4.17 0.15 
 
For partner versus self, inclusion of lymphatic invasion was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision partner versus 
self, fully adjusted model differences due to lymphatic invasion was illustrated in table 31 
and showed no significant influence in the fully adjusted model of decision partner versus 
self despite the lymphatic invasion whether it is positive or negative. 
Table 32 
 
Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for DifDaySurg 















Decision Partner Vs Self  Fully Adjusted Model Differences due to DifDaySurg  
The overall Type III p=0.22 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 




For partner versus self, inclusion of different day surgery was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision partner versus 
self, fully adjusted model differences due to different day surgery was illustrated in table 
32 and showed no significant influence in the fully adjusted model of decision partner 
versus self despite the choice of the patients to have CPM the same day of the surgery or  
 




Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Tumor Grade 






















Decision Partner Vs Self  Fully Adjusted Model Differences due to Tumor Grade  
The overall Type III p=0.62 

























For partner versus self, inclusion of tumor grade was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision partner versus self, fully 
adjusted model differences due to tumor grade was illustrated in table 33 and showed no 
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Decision Partner Vs Self  Fully Adjusted Model Logistic Regression for Path Stage 






























Decision Partner Vs Self  Fully Adjusted Model Differences due to Path Stage 
The overall Type III p=0.31 

















































For partner versus self, inclusion of pathological stage was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision partner versus 
self, fully adjusted model differences due to pathological stage was illustrated in table 34 
showed no significant influence in the fully adjusted model of decision partner versus self 





Decision Media Vs Self Fully Adjusted Model Logistic Regression 
 for Family History 















Decision Media Vs Self  Fully Adjusted Model Differences due to Family History   
The overall Type III p=0.44 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 True - False 0.32 0.41 1.37 0.61 3.1 0.44 
 
 
For media versus self, inclusion of family history was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to family history was illustrated in table 35 and showed 
no significant influence in the fully adjusted model of decision media versus self for 
patients with family history of breast cancer 
Table 36 
 
Decision Media Vs Self  Fully Adjusted Model Logistic Regression for Age 
Age Adj. 
Mean 
SE Probability CI95Min CI95Max 
31 to 40 years old 
 
41 to 50 years old 
 
20 to 30 years old 
 


























Decision Media Vs Self  Fully Adjusted Model Differences due to Age   











  41 to 50 years old-31 to 40 years old 
 
20 to 30 years old - 31 to 40 years old 
 
20 to 30 years old - 41 to 50 years old 
 
51 to 60 years old - 31 to 40 years old 
 
51 to 60 years old - 41 to 50 years old 
 








































For media versus self, inclusion of age was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to age was illustrated in table 36 and showed no 
significant influence in the fully adjusted model of decision Media versus self despite the 
age range of the patients. 
Table 37 
 










Black or African American 
 

































Decision Media Vs Self  Fully Adjusted Model Differences due to Race  










Hispanic/Latino – White or Caucasian 
 
Black or African American – Hispanic/Latino 
 
Black or African American - Hispanic/Latino 
 
Asian or Pacific Islander - White or Caucasian 
 
Asian or Pacific Islander - Hispanic/Latino 
 
Asian or Pacific Islander - Black or African 
American 
 
Other - White or Caucasian 
 
Other - Hispanic/Latino 
 
Other - Black or African American 
 






























































For media versus self, inclusion of race was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to race was illustrated in table 37 and showed no 
significant influence in the fully adjusted model of decision media versus self despite the 






Decision Media Vs Self Fully Adjusted Model Logistic Regression 
 for Partner 















Decision Media Vs Self  Fully Adjusted Model Differences due to Partner   
The overall Type III p=0.63 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 True - False 0.31 0.64 1.37 0.39 4.8 0.63 
 
For media versus self, inclusion of partner was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to partner was illustrated in table 38 and showed no 
significant influence in the fully adjusted model of decision media versus self despite 
whether the patient has a partner or not. 
Table 39 
 
Decision Media Vs Self  Fully Adjusted Model Logistic Regression for Education 
Education Adj.Mean SE Probability CI95Min CI95Max 
High school or GED 
 
Trade or technical school 
 



































Decision Media Vs Self  Fully Adjusted Model Differences due to Education  












 Trade or technical school-High school, or GED 
 
Junior college, or some college-High school or GED 
 
Junior college,  some college-Trade or technical school 
 
College graduate-High school or GED 
 
College graduate-Trade or technical school 
 
College graduate-Junior college or some college 
 
Postgraduate work or degree-High school or GED 
 
Postgraduate work or degree-Trade or technical school 
 
Postgraduate work or degree-Junior college or some 
college 
 
































































For media versus self, inclusion of education was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to education was illustrated in table 39 and showed no 
significant influence in the fully adjusted model of decision media versus self despite the 
education levels of the patients. 
Table 40 
 
Decision Media Vs Self  Fully Adjusted Model Logistic Regression for Receptor 


















Decision Media Vs Self  Fully Adjusted Model Differences due to Receptor  
The overall Type III p=0.78 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE -0.14 0.53 0.87 0.31 2.44 0.79 
 
For media versus self, inclusion of receptor was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to receptor was illustrated in table 40 and showed no 
significant influence in the fully adjusted model of decision media versus self despite the 
receptor status of the patients. 
Table 41 
 
Decision Media Vs Self  Fully Adjusted Model Logistic Regression for 
Lymphatic_Invasion 















Decision Media Vs Self  Fully Adjusted Model Differences due to Lymphatic_Invasion  
The overall Type III p=0.84 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 POS-NEG 0.11 0.52 1.11 0.4 3.07 0.84 
 
For media versus self, inclusion of lymphatic invasion was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision media versus 
self, fully adjusted model differences due to lymphatic invasion was illustrated in table 41 
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and showed no significant influence in the fully adjusted model of decision media versus 
self despite the lymphatic invasion whether it is positive or negative. 
Table 42 
 
Decision Media Vs Self  Fully Adjusted Model Logistic Regression for DifDaySurg 















Decision Media Vs Self  Fully Adjusted Model Differences due to DifDaySurg  
The overall Type III p=0.72 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE -0.22 0.61 0.81 0.24 2.68 0.72 
 
 
For media versus self, inclusion of different day surgery was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision media versus 
self, fully adjusted model differences due to different day surgery was illustrated in table 
42 and showed no significant influence in the fully adjusted model of decision media 
versus self despite the choice of the patients to have CPM the same day of the surgery or  
 




Decision Media Vs Self  Fully Adjusted Model Logistic Regression for Tumor Grade 
























Decision Media Vs Self  Fully Adjusted Model Differences due to Tumor Grade  
The overall Type III p=0.12 

























For media versus self, inclusion of tumor grade was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision media versus self, fully 
adjusted model differences due to tumor grade was illustrated in table 43 and showed no 




Decision Media Vs Self  Fully Adjusted Model Logistic Regression for Path Stage 








































Decision Media Vs Self  Fully Adjusted Model Differences due to Path Stage 
The overall Type III p=0.10 

















































For media versus self, inclusion of pathological stage was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision media versus 
self, fully adjusted model differences due to pathological stage was illustrated in table 44 
and showed no significant influence in the fully adjusted model of decision media 
versus self despite the pathological stage of the tumor. 
Table 45 
 
Decision Any Vs Self Fully Adjusted Model Logistic Regression 
 for Family History 















Decision Any Vs Self  Fully Adjusted Model Differences due to Family History   
The overall Type III p=0.044 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 




For any versus self, inclusion of family history was assessed by adding it to the model 
and comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to family history was illustrated in table 45 and showed 
significant influence in the fully adjusted model of decision any versus self for patients 
with family history of breast cancer. 
Table 46 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Age 
Age Adj. 
Mean 
SE Probability CI95Min CI95Max 
31 to 40 years old 
 
41 to 50 years old 
 
20 to 30 years old 
 






















Decision Any Vs Self  Fully Adjusted Model Differences due to Age   











  41 to 50 years old-31 to 40 years old 
 
20 to 30 years old - 31 to 40 years old 
 
20 to 30 years old - 41 to 50 years old 
 
51 to 60 years old - 31 to 40 years old 
 
51 to 60 years old - 41 to 50 years old 
 







































For any versus self, inclusion of age was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
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Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to age was illustrated in table 46 and showed no 
significant influence in the fully adjusted model of decision any versus self despite the 
age range of the patients. 
Table 47 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Race 
Race Adj. 
Mean 
SE Probability CI95Min CI95Max 




Black or African American 
 




















































Decision AnyVs Self  Fully Adjusted Model Differences due to Race  











Hispanic/Latino – White or Caucasian 
 
Black or African American – Hispanic/Latino 
 
Black or African American - Hispanic/Latino 
 
Asian or Pacific Islander - White or 
Caucasian 
 
Asian or Pacific Islander - Hispanic/Latino 
 
Asian or Pacific Islander - Black or African 
American 
 
Other - White or Caucasian 
 
Other - Hispanic/Latino 
 
Other - Black or African American 
 






























































For any versus self, inclusion of race was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to race was illustrated in table 47 and showed no 
significant influence in the fully adjusted model of decision any versus self despite the 














Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Education 
Education Adj. 
Mean 
SE Probability CI95Min CI95Max 
High school or GED 
 
Trade or technical school 
 
































Decision Any Vs Self  Fully Adjusted Model Differences due to Education  











 Trade or technical school-High school, or GED 
 
Junior college, or some college-High school or GED 
 
Junior college, or some college-Trade or technical 
school 
 
College graduate-High school or GED 
 
College graduate-Trade or technical school 
 
College graduate-Junior college or some college 
 
Postgraduate work or degree-High school or GED 
 
Postgraduate work or degree-Trade or technical school 
 
Postgraduate work or degree-Junior college or some 
college 
 

































































For any versus self, inclusion of education was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
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Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to education was illustrated in table 48 showed no 
significant influence in the fully adjusted model of decision any versus self despite the 
education levels of the patients. 
Table 49 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Receptor 















Decision Any Vs Self  Fully Adjusted Model Differences due to Receptor 
The overall Type III p=0.38 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE 0.3 0.34 1.35 0.69 2.62 0.38 
 
For any versus self, inclusion of receptor was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to receptor was illustrated in table 48 showed no 
significant influence in the fully adjusted model of decision any versus self despite the 
receptor status of the patients. 
Table 50 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Lymphatic_Invasion 
Lymphatic_Invasion Adj. 
Mean 

















Decision Any Vs Self  Fully Adjusted Model Differences due to Lymphatic_Invasion  
The overall Type III p=0.76 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 POS-NEG 0.09 0.3 1.1 0.61 1.97 0.76 
 
For any versus self, inclusion of lymphatic invasion was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision any versus 
self, fully adjusted model differences due to lymphatic invasion was illustrated in table 50 
and showed no significant influence in the fully adjusted model of decision any versus 
self despite the lymphatic invasion whether it is positive or negative. 
Table 51 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for DifDaySurg 















Decision Any Vs Self  Fully Adjusted Model Differences due to DifDaySurg  
The overall Type III p=0.50 
Contrast Estimate SE OddsRatio CI95Min CI95Max p-value 
 TRUE-FALSE -0.22 0.33 0.8 0.42 1.54 0.50 
 
For any versus self, inclusion of different day surgery was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision any versus 
self, fully adjusted model differences due to different day surgery was illustrated in table 
50 and showed no significant influence in the fully adjusted model of decision any versus 
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self despite the choice of the patients to have CPM the same day of the surgery or in a 
different day of the surgery. 
Table 52 
 
Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Tumor Grade 






















Decision Any Vs Self  Fully Adjusted Model Differences due to Tumor Grade  
The overall Type III p=0.97 


























For any versus self, inclusion of tumor grade was assessed by adding it to the model and 
comparing it to the model without the covariate based upon the Akaike Information 
Criteria (AIC). The result of the logistic regression of decision any versus self, fully 
adjusted model differences due to tumor grade was illustrated in table 52 showed no 







Decision Any Vs Self  Fully Adjusted Model Logistic Regression for Path Stage 





























Decision Any Vs Self  Fully Adjusted Model Differences due to Path Stage 
The overall Type III p=0.023 


















































For any versus self, inclusion of pathological stage was assessed by adding it to the 
model and comparing it to the model without the covariate based upon the Akaike 
Information Criteria (AIC). The result of the logistic regression of decision any versus 
self, fully adjusted model differences due to pathological stage was illustrated in table 53 
and showed significant influence in the fully adjusted model of decision any versus self 
when it came to the pathological stage of the tumor  especially for  patients with stage I-




Despite not being candidates for CPM, women with stage 0 to III early stage 
unilateral breast cancer ages 20-60 years old who underwent CPM at MD Anderson 
Cancer Center between January of 2010 and December of 2017 opted to have this 
irreversible surgery. 205 out of 345 
patients reported some doctor influence on the CPM decision. Sixty percent of 
patients’ decisions were influenced by doctors.  The model also showed that patients with 
a family history of breast cancer had significantly higher odds of doctor-influence than 
those without (p=.029, .040 with Hommel adjustment).  54 out of 190 patients with 
partners reported some partner influence on the CPM decision.  Twenty-eight percent of 
patients’ decisions were influenced by partners.  The model also showed that patients 
with a family history of breast cancer had significantly higher odds of partner-influence 
than those without (p=.023, .040 with Hommel adjustment).  36 out of 213 patients 
reported some level of media influence on the CPM decision.  Seventeen percent of 
patients’ decisions were influenced by media.  227 out of 35 patients reported some level 
of any influence on the CPM decision.  Sixty-eight percent of patients’ decisions were 
influenced by some combination of doctor, partner, or media. The model also showed 
that patients with a family history of breast cancer had significantly higher odds of any-
influence than those without (p=.040, .040 with Hommel adjustment).    
No matter how small their risk was to develop contralateral breast cancer CBC), these 
women chose developing CBC as their principal concern. The analysis demonstrates that 
partners, physicians, and media had significant influence on the decision-making process 
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of women with unilateral breast cancer to undergo CPM. In Chapter 5, I will discuss the 





Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this study was to assess the influence of the physician, partner, 
and media on women’s decision making with regards to the utilization of CPM among 
women with early stage unilateral breast cancer and to determine to what extent their 
decision was influenced by their physician, partner, and media. Despite not being 
candidates for CPM, the results of this study indicated that women with stage 0 to III 
early stage unilateral breast cancer ages 20-60 years old who underwent CPM at MD 
Anderson Cancer Center between January of 2010 and December of 2017 who opted to 
have this irreversible surgery reported not making the decision alone. Key findings of this 
study are that partners, physicians, and media all had significant influence (p < 0.005) on 
the decision-making process of women with unilateral breast cancer to undergo CPM. 
Chapter 5 gives a final overview of the findings and its interpretation in the context of the 
theoretical shared decision-making theory, limitations to generalizability, implications of 
the study, recommendations for future research, and the impact of the study for positive 
social change. 
Interpretation of the Findings 
CPM is one of many decisions that involve a choice where the outcome is not 
certain. Patients should make an informed decision when it comes to this irreversible 
procedure. Shared decision-making theory was used in order to resolve the confliction 
between patient self-determination and practitioners’ responsibility and to confirm that 
decisions are evidence-based and in patients’ interests (Brown & Salmon, 2018). The 
shared model of decision making is the derivative of the normative decision theory and 
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was used in my research study as the theoretical framework. Breast cancer patients are 
consumers of medical care and have the right to actively participate in the decision-
making process concerning treatment choices and risk reduction strategies. The 
normative decision theory includes an active attempt to engage patient values in the 
decision-making process. In order to accomplish this goal, patients should be provided 
with decision aids such as informative brochures, videos, computer programs, as well as 
physicians inputs.  
Breast cancer patients should be provided with enough information and 
opportunity to decide among treatment options consistent with the informed consent 
process. Treatment options should be discussed with a patient in a culturally competent 
manner, including the option of no treatment at all. Discussion should include all current 
treatments a consumer may be undergoing and risks, benefits, and consequences to 
treatment or non-treatment. Patients should be given the opportunity to refuse treatment 
and to express preferences about future treatment decisions. 
Achieving shared decision-making depends on building a good relationship 
between the physician and the patients in the clinical encounter in order for the 
information to be shared with breast cancer patients and allow patients to express and 
deliberate their preferences regarding their treatment options during the decision-making 
process (Elwyn et al., 2012). The patient decision may be influenced by their partner, 
physician, or the media, and patients should play an active role in making an informed 
decision regarding the treatment options. The SDM approach gives patients and 
physicians the opportunity to jointly decide which medical treatment option is best based 
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on current evidence and patient’s needs and preferences (Elwyn et al., 2012). Patients' 
decision can be compromised and affected by the disease or the stressful situations such 
as the new diagnosis of breast cancer; for this reason, patients should be provided with 
tools and education that help them make an informed decision. The results of this study 
emphasize that despite not being candidates for CPM, women with stage 0 to III early 
stage unilateral breast cancer ages 20-60 years old who underwent CPM at MD Anderson 
Cancer Center between January of 2010 and December of 2017 opted to have this 
irreversible surgery. Two hundred five out of 345 patients reported some doctor influence 
on the CPM decision, Fifty four out of 190 patients with partners reported some partner 
influence on the CPM decision, this compares to 36 out of 213 patients who reported 
some level of media (television, newspapers, social media, magazines, and radio) 
influence on the CPM decision. When asked about the reason to have the CPM surgery, 
50.5% (186) of the women cited breast cancer prevention as the main reason for choosing 
CPM.  
The findings of the study correlated with the literatures that show that regardless 
of knowing that CPM does not improve survival rate, many women with unilateral breast 
cancer are choosing this procedure in order to ease their fear and potentially extend their 
lives (Rosenberg et al., 2013). Despite not being candidates for CPM, the result of the 
study demonstrated that women with stage 0 to III early stage unilateral breast cancer 
ages 20-60 years old who underwent CPM at MD Anderson Cancer Center between 
January of 2010 and December of 2017 opted to have this irreversible surgery. The 
analysis demonstrates that partners, physicians, and media had significant influence on 
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the decision-making process of women with unilateral breast cancer to undergo CPM.  
The findings could highlight the need for decision aid programs or tools that help breast 
cancer women increase their knowledge of their treatment options, reduce their decisional 
conflicts, and make informed decisions that align with their goals and values. It is 
important for women with unilateral breast cancer to fully understand the benefits versus 
the adverse effects of CPM and make an informed decision regarding this irreversible 
surgical procedure. 
Limitations of the Study 
The limitation to the study is that the patients that were evaluated for the research 
study are inherent to one single institution which might affect the external validity or the 
generalizability of the study findings. The response bias that might affect my research; 
the breast cancer patients can consciously or unconsciously give responses that they think 
that the person conducting the research might want to see. In order to address the 
response bias limitation, clear language was used in the survey to avoid any clarification 
to certain questions, the questions were not framed in a way that I was most likely to get 
the answer I wanted to hear, the amount of options were not confusing, and the reason for 
conducting the survey was communicated in the introduction part of the survey.  
Women were selected from the surgical breast cancer database at MD Anderson 
Cancer Center. The alpha for the test of this model was set at 0.05. In order to achieve 
power of 0.80 and a medium effect size, a sample of 384 was required in order to detect 
differences in the research study.  
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The binary influence variables which formed the basis of these analyses were not 
independent.  Most patients reporting influence from partners or media also report 
influence from doctors.  Two-thirds of patients reported some form of influence; taken 
together, the results suggest that a patient with a family history of breast cancer appears 
more likely to consider external perspectives in her decision to have a CPM. 
Recommendations 
This study was needed because the findings of the study highlight the need for 
developing a decision quality tool that helps women with early stage unilateral breast 
cancer make informed decisions regarding their surgical choices. While researchers may 
know the factors that are influencing the decision-making process of women with 
unilateral breast cancer to undergo CPM, prospective research is needed in order to 
develop a decision quality tool that helps women with unilateral breast cancer make an 
informed decision regarding their surgical choice. The decision quality tool can be a 
brochure that includes but not limited to the indication for the CPM procedure, the 
necessity and the medically unnecessary indication of the procedure, doctor’s 
recommendation, the pro and cons of the procedure, the complications, and frequently 
asked questions, as well as feedbacks from patients who did and did not choose CPM. 
The patient should have good knowledge regarding the irreversible procedure so they can 
make a shared informed decision about their treatment options. Future qualitative studies 
are needed in order to determine whether the decision to have a breast reconstruction was 
the main reason why patients opted to undergo prophylactic mastectomy, and whether the 





The potential contribution of the study to advance practice and promote positive 
social change is that it could help in assessing the influence of the partner, physician, and 
media on the decision of women with unilateral breast cancer who decided to undergo 
CPM, and the findings could highlight the need of decision aids programs or tools that 
help breast cancer women increase their knowledge of their treatment options, reduce 
their decisional conflicts, and make informed decisions that align with their goals and 
values. It is important for women with unilateral breast cancer to fully understand the 
benefits versus the adverse effect of CPM and make an informed decision regarding the 
irreversible surgical procedure. Evidence driven models are needed to better inform 
women about their risk of contralateral breast cancer in order to empower them in their 
active decision-making process (Yi et al., 2009). No matter how small the risk was for 
study participants to develop contralateral breast cancer (CBC), these women choose 
developing CBC as their principal concern for having CPM. Women should understand 
their risk of local, contralateral and systemic recurrence and that opting to choose the 
irreversible CPM procedure will not affect these risks equally (Rosenberg et al., 2015). 
The normative decision theory includes an active attempt in order to engage 
patient’s values in the decision-making process. In order to accomplish this goal, patients 
are provided with decision aids such as informative brochures, videos, computer 
programs, as well as physician’s inputs (Elwyn et al., 2012). This model is 
conceptualized as providing the patient with both objective medical information 
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incorporated with her subjective values and opinions (Elwyn et al., 2012). The shared 
model of decision-making is the derivative of the normative decision theory. SDM should 
not be confused by obtaining an informed consent from patient. Informed consent is 
mandated by ethical guidelines; while SDM is a process by which the physician and the 
patient consider valuable information regarding the medical problem in question which 
may include treatment options and consequences, which allows the patients to consider 
how the treatment plan can fit with their preferences for health states and outcomes. 
When faced with life threatening diseases like breast cancer, patients might make 
uninformed decisions regarding their treatment. Patients might also overestimate the 
benefits of CPM and others may underestimate the severity of some of the side effects 
associated with this procedure. It is important for women with unilateral breast cancer to 
fully understand the benefits as well as the side effects that are associated with CPM in 
order to make informed and supported decisions, based on accurate understanding of the 
pros versus the cons of the procedure.  
Decision-making surrounding early diagnosis of breast cancer, with respect to 
CPM option, and by using a shared decision-making approach, gives patients and 
physicians the opportunity to jointly decide which medical treatment option is best based 
on current evidence and patient’s needs and preferences (Rosenberg, & Partridge, 2014). 
A clinical educational instrument is important to help women with unilateral breast 
cancer make informed decision regarding CPM, and to improve the quality of life of 
breast cancer survivors. Providing patients with educational instrument will empower 
them to be effective advocate of their health and the treatment options and better 
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understand their health conditions. Many patients have limited health information which 
can be more complicated when combined with fear and decision-making providing 
vulnerable patients with an informational tool in a format that they can easily understand 
could improve the quality of their medical care and promote informed decision-making. 
Conclusion 
 When faced with life threatening diseases like breast cancer, patients might make 
uninformed decisions regarding their treatment. They might also overestimate the 
benefits of CPM and others may underestimate the severity of some of the side effects 
associated with this procedure. It is important for women with unilateral breast cancer to 
fully understand the benefits as well as the side effects that are associated with CPM in 
order to make informed and supported decisions, based on accurate understanding of the 
benefits versus the risks of the procedure. Decision-making surrounding early diagnosis 
of breast cancer, with respect to CPM option, and by using a shared decision-making 
approach, gives patients and physicians the opportunity to jointly decide which medical 
treatment option is best based on current evidence. A clinical educational instrument 
would be important to help women with unilateral breast cancer make informed decision 
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Contralateral Prophylactic Mastectomy Survey 
Living with Breast Cancer Risk:  Survey of Experiences and Decision-Making Process 
Please check the one best answer to each of the following questions, unless 
instructed otherwise. 
 Your Breast Cancer Experience and Thoughts  
 
 
1. Before your contralateral prophylactic mastectomy, how would you have described 
your concern about developing breast cancer?  
 
 4 Very concerned 
 3 Concerned 
 2 Not very concerned 
 1 Not concerned at all 
  
 
2. At the time of your prophylactic mastectomy, what was your marital status?  
 
 1 Married 
 2 Living together but unmarried 
 3 Separated or divorced 
 4 Widowed 
 5 Single, never married 
 
3. What were your reasons for having a contralateral prophylactic mastectomy?  
Please check all that apply.  
 
 1 Uncomfortably large breasts 
 2 Concerns about appearance 
 3 Family history of breast cancer 
 4 Prevent breast cancer 
 5 Other, please specify: __________________________________________  
 
   4. Which statement (s) best describes the decision about your contalateral prophylactic 
mastectomy? Choose all that apply. 
 
 1 I made the final decision to have surgery. 
 2 I made the final decision to have surgery after seriously considering my doctor's 
opinion. 
 3 My doctor and I shared responsibility for the final decision to have surgery. 
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 4 My doctor made the final decision about my surgery, but seriously considered my 
opinion. 
 5 My doctor made the final decision about my surgery. 
 
              6 I made the final decision to have surgery after seriously considering my partner's 
opinion. 
 7 My partner made the final decision about my surgery. 
 
5.  Media Influence: Please choose one number to indicate whether or not the media had 


















     
1 2 3 4 5 
 
 
6. Thinking back to six months after your prophylactic mastectomy, how satisfied were you 
with your decision to have the surgery? 
 
1 Very dissatisfied 
2 Dissatisfied 
3   Neither Satisfied or Dissatisfied 
4 Satisfied 
5 Very satisfied 
 
 
7. Did you have breast reconstruction after your prophylactic mastectomy? Breast 
reconstruction is a surgical procedure in which the breasts are recreated using implants 
or tissue from the body.  
 
 0 No.   
 1 Yes, done in a separate surgery after the prophylactic mastectomy 
 2 Yes, done along with prophylactic mastectomy 
 
8. I “yes” Have you had surgery to revise or repair your reconstruction?  
 
 0 No 
 1 Yes, one or two times 






Your Life Right Now 
 
9. Below is a list of statements that describe aspects of women’s lives, including thoughts 
about your body and sexuality.  
 
Please choose one number to indicate how true each 























      
a. I am able to enjoy life. 1 2 3 4 5 
      
b. I am content with the quality of my life 
right now. 
1 2 3 4 5 
      
c. I feel self-conscious about my appearance. 1 2 3 4 5 
      
d. I am happy with my current weight. 1 2 3 4 5 
      












      
f. I find it difficult to look at myself naked. 1 2 3 4 5 
      
g. I am embarrassed for others to see my 
body. 
1 2 3 4 5 
      
h. I am able to feel like a woman. 1 2 3 4 5 
      
i. I feel sexually attractive. 1 2 3 4 5 
      




A Few Details About You 
 
10. What was your age at the time of prophylactic mastectomy? 
 
               1 20 to 30 years old 
 2 31 to 40 years old 
 3 41 to 50 years old 
 4 51 to 60 years old  
 
11. To what race/ethnic group do you belong?  Please check all that apply.  
 
 1 Asian or Pacific Islander, please specify:       
 2 Black or African American  
 3 Hispanic/Latino, please specify:        
 4 Native American or Alaskan Native 
 5 White or Caucasian  
 9 Other, please specify:         
 
12. What is the highest level of education you have completed?  
 
 1 Less than or some high school 
 2 High school or GED 
 3 Trade or technical school 
 4 Junior college, or some college 
 5 College graduate 
 6 Postgraduate work or degree 
 
13. On what date did you complete this questionnaire?  
 
 ____/____/____ (month/day/year)   
 







15. Overall, how satisfied are you now with your decision to have contralateral prophylactic 
mastectomy? 
 


















Thank you very much for completing the survey! 
